Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,Ribosome,-0.8277367090217629,-2.956425737821124,0.0,0.0,0.0,95/127,11.54%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPS3A1;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPL24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL13;RPL38;RPL29;RPL27;RPL22;RPL17;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPS18;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;MRPL36;RPL32;RPL36A;MRPL18;MRPL23;MRPS21;MRPL14;RPL36AL;RPS26;RPL10;MRPL9;MRPL30;MRPL33;MRPS14;MRPL11;RPS13;RPL35;MRPS16;RPLP0;MRPL17;MRPS5;RPS27L;MRPL19;RPL10A
gsea,Parkinson disease,-0.7367098172505833,-2.81470016823097,0.0,0.0,0.0,79/109,16.52%,UBB;SLC25A4;ATP5B;CYC1;COX6C;UQCRQ;NDUFA3;COX8A;NDUFS5;NDUFA1;ATP5H;PARK7;ATP5O;COX4I1;COX5B;COX7C;ATP5J;SLC25A5;VDAC1;NDUFA4;COX6B1;COX6A1;UQCRB;COX7A2L;ATP5D;ATP5E;NDUFS8;UQCR10;COX5A;ATP5G2;COX7A2;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;UQCRC1;COX7B;UBE2J1;CYCS;ATP5G3;ATP5A1;ATP5G1;UQCR11;NDUFB8;SNCA;UQCRC2;NDUFC2;PINK1;NDUFV2;UBA1;VDAC3;ATP5C1;NDUFA7;NDUFA8;GNAI1;NDUFC1;NDUFV1;NDUFB6;UCHL1;NDUFA5;GNAI2;VDAC2;SDHD;SLC18A2;SDHB;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;GPR37;NDUFB7;PRKACB;NDUFB2
gsea,Oxidative phosphorylation,-0.7456609664547273,-2.783523373975333,0.0,0.0,0.0,76/104,16.61%,ATP6V0C;ATP5B;ATP6V1D;CYC1;COX6C;ATP6V1A;UQCRQ;NDUFA3;COX8A;NDUFS5;NDUFA1;ATP5H;ATP5O;COX4I1;ATP6V1G2;COX17;COX5B;ATP6V0E2;COX7C;ATP5J;NDUFA4;COX6B1;COX6A1;UQCRB;COX7A2L;ATP5D;ATP5E;NDUFS8;UQCR10;ATP6V0B;COX5A;ATP5G2;COX7A2;NDUFS2;NDUFB3;UQCRH;NDUFA2;ATP5K;NDUFS7;NDUFB10;ATP6V1F;NDUFA13;NDUFB11;ATP5L;UQCRC1;COX7B;ATP5G3;ATP5A1;ATP5G1;UQCR11;NDUFB8;UQCRC2;NDUFC2;ATP6V1E1;NDUFV2;ATP5C1;NDUFA7;NDUFA8;ATP5J2;NDUFC1;NDUFV1;NDUFB6;NDUFA5;ATP6V1C1;SDHD;SDHB;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;NDUFB7;ATP6V1B2;NDUFB2;ATP6V1G1
gsea,Alzheimer disease,-0.6552905082912149,-2.7047087754723247,0.0,0.0,0.0,76/137,14.43%,CALM1;CALM2;GAPDH;CALM3;ATP5B;APOE;CYC1;PPP3CA;COX6C;UQCRQ;NDUFA3;COX8A;NDUFS5;NDUFA1;ATP5H;ATP5O;COX4I1;COX5B;COX7C;ATP5J;NDUFA4;COX6B1;COX6A1;UQCRB;COX7A2L;ATP5D;ATP5E;NDUFS8;UQCR10;COX5A;ATP5G2;COX7A2;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;UQCRC1;PSENEN;COX7B;PPP3R1;CYCS;ATP5G3;ATP5A1;ATP5G1;PPP3CB;UQCR11;NDUFB8;SNCA;UQCRC2;CDK5R1;NDUFC2;NDUFV2;APH1A;ATP5C1;NDUFA7;NDUFA8;BAD;RTN4;NDUFC1;NDUFV1;NDUFB6;NDUFA5;GSK3B;SDHD;SDHB;MAPK3;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA
gsea,Huntington disease,-0.6310663795022607,-2.6956398270465267,0.0,0.0,0.0,90/157,19.25%,SLC25A4;ATP5B;CYC1;COX6C;UQCRQ;NDUFA3;COX8A;NDUFS5;NDUFA1;ATP5H;ATP5O;COX4I1;COX5B;COX7C;ATP5J;SLC25A5;CLTA;VDAC1;NDUFA4;COX6B1;COX6A1;UQCRB;COX7A2L;ATP5D;ATP5E;NDUFS8;UQCR10;BDNF;AP2M1;COX5A;ATP5G2;COX7A2;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;BAX;NDUFA13;NDUFB11;UQCRC1;COX7B;SOD1;CYCS;ATP5G3;POLR2F;ATP5A1;ATP5G1;UQCR11;NDUFB8;POLR2I;UQCRC2;NDUFC2;NDUFV2;VDAC3;ATP5C1;POLR2G;NDUFA7;NDUFA8;POLR2E;NDUFC1;TBPL1;NDUFV1;DNAL4;POLR2C;NDUFB6;NDUFA5;VDAC2;AP2B1;SDHD;SDHB;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;TFAM;NDUFB7;CLTB;NDUFB2;CREB3L2;AP2S1;NDUFAB1;UQCRFS1;NDUFA10;POLR2J;NDUFA11;CREB1
gsea,Non-alcoholic fatty liver disease (NAFLD),-0.6138510377401846,-2.589911287279578,0.0,0.0,0.0,65/118,18.95%,CYC1;RAC1;COX6C;UQCRQ;NDUFA3;JUN;COX8A;NDUFS5;NDUFA1;COX4I1;COX5B;COX7C;NDUFA4;COX6B1;COX6A1;UQCRB;COX7A2L;CDC42;NDUFS8;UQCR10;COX5A;COX7A2;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;BAX;NDUFA13;NDUFB11;UQCRC1;COX7B;CYCS;UQCR11;NDUFB8;IRS2;UQCRC2;NDUFC2;NDUFV2;NDUFA7;NDUFA8;NDUFC1;NDUFV1;NDUFB6;NDUFA5;XBP1;GSK3B;SDHD;PIK3R1;SDHB;CEBPA;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;ADIPOR2;NDUFB7;NDUFB2;NDUFAB1;UQCRFS1;NDUFA10;NDUFA11
gsea,Thermogenesis,-0.5377407399711834,-2.425015601292214,0.0,0.0,0.0,94/187,19.25%,ACTB;ATP5B;GNAS;CYC1;COX6C;UQCRQ;NDUFA3;ACTG1;COX8A;RPS6;NDUFS5;NDUFA1;ATP5H;ACSL3;ATP5O;COX4I1;COX17;COX5B;COX7C;ATP5J;NDUFA4;COX6B1;COX6A1;UQCRB;COX7A2L;ATP5D;COA3;ATP5E;NDUFS8;UQCR10;COX5A;ATP5G2;COX7A2;NDUFS2;NDUFB3;UQCRH;NDUFA2;RHEB;ATP5K;NDUFS7;NDUFB10;NDUFA13;NDUFB11;ATP5L;UQCRC1;COX7B;ATP5G3;ATP5A1;ATP5G1;UQCR11;NDUFB8;KRAS;UQCRC2;NDUFC2;NDUFV2;ATP5C1;FGFR1;NDUFA7;NDUFA8;ATP5J2;HRAS;COX14;COX20;NDUFC1;NDUFV1;NDUFB6;NDUFA5;SDHD;SDHB;COA7;COX19;ADCY10;ATF2;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;NDUFAF2;SMARCE1;SIRT6;NDUFB7;PRKACB;AKT1S1;NDUFB2;CREB3L2;NDUFAB1;UQCRFS1;NDUFAF3;NDUFA10;ACTL6B;NDUFA11;CREB1
gsea,Proteasome,-0.6696332185743419,-2.3648694082525212,0.0,0.0,0.0,25/40,16.75%,PSMC3;PSMB5;PSMA7;PSMC2;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;POMP;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;ADRM1;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2
gsea,Nicotine addiction,0.6908002122836762,2.3400619629517894,0.0,0.0,0.0,10/31,2.06%,GRIA3;GRIN2A;GRIA1;GRIN1;CACNA1A;GABRA2;GRIA4;GABRG3;CACNA1B;CHRNA4
gsea,Ferroptosis,-0.6618085995744001,-2.3219810276482176,0.0,0.0,0.0,12/35,12.08%,FTH1;PRNP;ACSL3;FTL1;GPX4;MAP1LC3B;TRF;PCBP1;VDAC3;GCLM;MAP1LC3A;VDAC2
gsea,Cardiac muscle contraction,-0.5677149957372053,-2.242787232380291,0.0,0.0,0.0,24/58,7.25%,ATP1B1;CYC1;COX6C;UQCRQ;COX8A;ATP1A1;COX4I1;COX5B;COX7C;COX6B1;ATP1A3;COX6A1;UQCRB;COX7A2L;UQCR10;COX5A;COX7A2;UQCRH;UQCRC1;COX7B;ATP1B2;TPM1;UQCR11;UQCRC2
gsea,Taste transduction,0.6484669742036332,2.1681496629491677,0.0,0.0005455537370430987,0.002,8/28,3.12%,CACNA1C;CACNA1A;ASIC2;GABRA2;PDE1A;GABBR2;ADCY8;CHRM3
gsea,Necroptosis,-0.5067752969462006,-2.116456178357,0.0,0.00038685862735036763,0.003,25/85,16.46%,FTH1;HSP90AB1;SLC25A4;HMGB1;PPIA;HSP90AA1;SLC25A5;VDAC1;SQSTM1;FTL1;BAX;SPATA2L;GLUL;IFNGR2;CHMP4B;VDAC3;CHMP2A;PARP1;SPATA2;CHMP6;VDAC2;VPS4A;SHARPIN;CAMK2B;CHMP4C
gsea,Mineral absorption,-0.6342749150462323,-2.1161752178425197,0.0,0.0003546204084045037,0.003,11/28,11.75%,FTH1;ATP1B1;MT1;ATP1A1;ATP1A3;FTL1;ATP1B2;TRF;ATP1A2;HMOX2;ATP2B1
gsea,Phagosome,-0.5240469751439941,-2.1118786679729076,0.0,0.0003273419154503111,0.003,32/83,16.61%,ACTB;ATP6V0C;TUBA4A;ATP6V1D;TUBB2A;RAC1;ATP6V1A;TUBA1A;ACTG1;CALR;ATP6V1G2;ATP6V0E2;TUBB5;STX7;ATP6V0B;ATP6V1F;CANX;TUBB2B;TUBB4A;LAMP1;TUBB4B;ATP6V1E1;ITGAV;SEC61G;NCF2;TUBA1B;ATP6V1C1;H2-M5;VAMP3;LAMP2;ATP6V1B2;ATP6V1G1
gsea,Gastric acid secretion,-0.5450435494455487,-2.1040485404515934,0.0,0.0004052804667480042,0.004,21/54,17.14%,CALM1;ATP1B1;CALM2;ACTB;CALM3;GNAS;ATP1A1;ATP1A3;KCNK2;KCNJ2;ATP1B2;GNAI1;ATP1A2;MYLK3;KCNJ16;GNAI2;EZR;SSTR2;PRKACB;CAMK2B;CAR2
gsea,Spliceosome,-0.468138620136594,-2.09129063816725,0.0,0.0003782617689648039,0.004,57/126,23.49%,DDX5;HSPA8;ZMAT2;SNRPG;SNW1;WBP11;SNRPF;HSPA2;SNRPD2;SNRNP27;SF3B2;SNU13;SF3B4;RBM8A;HNRNPA1;PCBP1;MAGOH;RBM22;LSM7;BUD31;LSM4;LSM2;PUF60;U2AF1;CCDC12;CTNNBL1;HNRNPK;SNRNP200;SNRPD1;MAGOHB;SRSF3;LSM8;TXNL4A;SNRPE;RBMXL1;SYF2;U2AF1L4;HNRNPC;PHF5A;SF3B6;U2AF2;CDC40;PRPF19;SLU7;PQBP1;LSM5;DDX39B;SNRPC;CWC15;SART1;NCBP2;SNRPB;RP9;PPIE;HNRNPA3;PRPF38A;BCAS2
gsea,Rheumatoid arthritis,-0.6018020975910426,-2.0549150904260003,0.0,0.0009752061231123852,0.01,14/33,16.61%,ATP6V0C;ATP6V1D;ATP6V1A;JUN;ATP6V1G2;ATP6V0E2;ATP6V0B;ATP6V1F;IL18;ATP6V1E1;TEK;ATP6V1C1;ATP6V1B2;ATP6V1G1
gsea,Glutathione metabolism,-0.5727653964960165,-2.043252676572643,0.0,0.001001281153142128,0.011,16/34,22.22%,GSTM5;GSTM1;GPX4;GSTP1;SRM;NAT8F1;HPGDS;GCLM;ODC1;GSTO1;RRM1;SMS;IDH2;RRM2B;LAP3;GSTM7
gsea,Legionellosis,-0.5738523081800768,-2.020755733980589,0.0,0.0010244589576130106,0.012,12/34,14.55%,EEF1A1;HSPA8;ARF1;EEF1G;EEF1A2;HSPA2;NFKB2;CYCS;IL18;RAB1B;SAR1A;HSPD1
gsea,Fluid shear stress and atherosclerosis,-0.4668146485451822,-2.0145298432738232,0.0,0.0011945108493625386,0.015,17/99,7.62%,CALM1;CALM2;HSP90AB1;ACTB;CALM3;RAC1;ACTG1;HSP90AA1;JUN;GSTM5;SUMO2;GSTM1;MEF2C;SQSTM1;GSTP1;PDGFA;ITGAV
gsea,Antigen processing and presentation,-0.5752372319604675,-2.006318065440817,0.0018115942028985507,0.0012766334702562132,0.017,11/36,13.76%,HSP90AB1;HSPA8;HSP90AA1;CALR;HSPA2;CANX;PDIA3;CTSB;NFYB;PSME3;H2-M5
gsea,Glycolysis / Gluconeogenesis,-0.559560512406289,-1.9932690659387065,0.001876172607879925,0.0016211218669920167,0.023,19/42,20.64%,GAPDH;ALDOA;PGAM1;PKM;ALDOC;TPI1;PGK1;ENO2;DLAT;LDHA;G6PC3;LDHB;PGAM2;PFKL;ADH5;AKR1A1;ENO1;HK1;MINPP1
gsea,Collecting duct acid secretion,-0.6908756628795044,-1.9916516388668097,0.0,0.0015474345094014705,0.023,11/18,17.14%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;ATP6V1F;ATP6V1E1;ATP6V1C1;ATP6V1B2;ATP6V1G1;CAR2
gsea,Protein export,-0.6053128174157411,-1.9733083276983872,0.0019157088122605363,0.0017885203206488012,0.028,17/26,25.26%,SEC62;SRP14;SPCS2;ARXES1;SRP9;IMMP2L;SEC61G;ARXES2;SRP19;SRPR;SPCS1;SRP72;OXA1L;SRPRB;SEC61B;SEC11C;SEC63
gsea,RNA transport,-0.43004467963839915,-1.9539300207834258,0.0,0.002127722450427022,0.034,52/143,23.75%,EEF1A1;EIF1;RAN;EIF4A1;EIF1B;SUMO2;EEF1A2;EIF3C;EIF4A2;EIF1AX;PABPC4;EIF3H;EIF3F;EIF3A;POP5;SAP18;EIF5B;RBM8A;RPP21;MAGOH;EIF2S2;EIF3I;NUP50;EIF5;PABPC1;FMR1;EIF1A;DDX20;MAGOHB;EIF4EBP2;GEMIN7;NUP37;NUP205;SEH1L;SEC13;UPF3A;NUP107;EIF4G2;GEMIN6;CLNS1A;EIF2B5;EIF3D;DDX39B;UPF2;THOC7;RPP38;POP4;NCBP2;NUP35;RPP25L;SUMO1;TGS1
gsea,Cholesterol metabolism,-0.58808046745328,-1.9464936682808176,0.001937984496124031,0.0022128313484441027,0.037,11/27,14.46%,APOE;NCEH1;VDAC1;VAPA;LRPAP1;LCAT;VDAC3;VDAC2;LDLR;PLTP;ANGPTL3
gsea,Drug metabolism,-0.5128939189790924,-1.9422230682838633,0.001851851851851852,0.002345950394060563,0.041,22/43,22.22%,GSTM5;NME7;NME2;GSTM1;GSTP1;HPGDS;ITPA;UCKL1;NME4;TK2;DUT;HPRT;GUSB;NME1;IMPDH2;ADH5;GMPS;GSTO1;RRM1;RRM2B;MAOB;GSTM7
gsea,Proximal tubule bicarbonate reclamation,-0.6608412279498822,-1.931797387246276,0.0,0.0023641360560300246,0.043,6/18,10.01%,ATP1B1;ATP1A1;ATP1A3;MDH1;ATP1B2;ATP1A2
gsea,Citrate cycle (TCA cycle),-0.579689283964606,-1.9153381873288182,0.0,0.0027356431505490284,0.05,13/28,22.22%,IDH3B;MDH2;MDH1;DLAT;IDH3A;SUCLG1;SDHD;SDHB;ACLY;SDHA;IDH3G;IDH2;SDHC
gsea,Pertussis,-0.5425290435323427,-1.9029796737788431,0.0,0.003228268545475482,0.058,15/38,21.21%,CALM1;CALM2;CALM3;JUN;CFL1;CFL2;GNAI1;IRF8;GNAI2;MAPK3;C1QB;IRAK4;MAPK1;IRF3;RHOA
gsea,Oocyte meiosis,-0.44965722034165506,-1.884955161074445,0.0,0.004113596737492243,0.077,18/85,6.61%,CALM1;CALM2;CALM3;YWHAG;PPP3CA;YWHAH;YWHAB;YWHAE;PPP3R1;PPP1CA;SMC1A;YWHAZ;PPP2CA;PPP3CB;PPP2R1A;YWHAQ;ANAPC13;RBX1
gsea,Bacterial invasion of epithelial cells,-0.48117492180007765,-1.8830392627807553,0.001893939393939394,0.004118172484697462,0.079,17/57,14.16%,ACTB;RAC1;ACTG1;CLTA;CDC42;ARPC5;CTNNA3;WASL;ARPC5L;ARPC2;ARPC1A;ARPC3;CTNNA1;PIK3R1;VCL;ARPC4;ILK
gsea,Kaposi sarcoma-associated herpesvirus infection,-0.42522217681066754,-1.867703675343823,0.0,0.004698720411359674,0.091,37/125,20.33%,CALM1;CALM2;UBB;CALM3;GABARAPL1;RAC1;PPP3CA;JUN;GNB2;GNG2;GABARAPL2;BAX;GABARAP;PPP3R1;CYCS;PPP3CB;KRAS;GNG13;CDK4;GNG10;HRAS;GNG3;GSK3B;ANGPT2;LYN;PIK3R1;MAPK3;H2-M5;RCAN1;HCK;ATG3;PDGFB;CREB1;MAPK1;NFKBIA;TBK1;IRF3
gsea,Alcoholism,-0.4353120001968618,-1.8527582313986388,0.0,0.005459005074832966,0.106,21/85,13.02%,CALM1;CALM2;H3F3B;H3F3A;CALM3;GNAS;GNB2;GNG2;BDNF;PPP1CA;KRAS;GNG13;GNG10;HRAS;GNG3;GNAI1;GNAI2;PPP1R1B;SLC18A2;ATF2;MAPK3
gsea,Type II diabetes mellitus,0.5271388273013727,1.8374082517719585,0.0,0.027641389343517,0.119,12/33,10.86%,CACNA1C;CACNA1E;CACNA1A;GCK;PRKCE;MAPK10;CACNA1B;PIK3R3;IKBKB;SOCS2;PIK3CD;MTOR
gsea,Glutamatergic synapse,0.4155200323129143,1.7961947757793901,0.0,0.033006001091107476,0.175,26/95,9.46%,GRIK4;CACNA1C;GRIA3;DLGAP1;GRIN2A;SHANK2;GRIA1;GRIN1;CACNA1A;GRIA4;ADCY8;ADCY2;PRKCG;GRM8;PLA2G4E;GRIK5;GRIK2;SHANK3;SHANK1;GRM7;ADCY9;GRK3;GRIK1;SLC1A1;GNAO1;ADCY6
gsea,Cysteine and methionine metabolism,-0.49988012341492394,-1.7902148815125856,0.001937984496124031,0.011139252828706174,0.195,9/35,9.94%,MDH2;MDH1;TST;SRM;MAT2B;LDHA;GOT2;GCLM;LDHB
gsea,Prion diseases,-0.5538281547142058,-1.7831165350601408,0.001968503937007874,0.012036829862415726,0.214,11/22,22.35%,PRNP;NCAM2;BAX;SOD1;EGR1;MAPK3;C1QB;PRKACB;MAPK1;NCAM1;PRKACA
gsea,Estrogen signaling pathway,-0.4188772453398589,-1.7788919426242447,0.0,0.012096496153353627,0.221,24/88,16.95%,CALM1;CALM2;HSP90AB1;KCNJ3;CALM3;GNAS;HSPA8;HSP90AA1;JUN;KRT10;HSPA2;KRAS;HRAS;GNAI1;GABBR1;GNAI2;PIK3R1;ATF2;MAPK3;GRM1;PRKACB;FKBP4;CREB3L2;OPRM1
gsea,Protein processing in endoplasmic reticulum,-0.3797816175684593,-1.7698911705578049,0.0,0.013264720141400893,0.248,56/147,25.53%,HSP90AB1;HSPA8;HSP90AA1;SEC62;CALR;DNAJA1;DNAJA2;HSPA2;BAX;CANX;PDIA3;UBE2J1;PDIA6;DAD1;RBX1;UBQLN2;BAG1;DDOST;SEC61G;SSR3;LMAN2;SSR2;STUB1;RNF5;FBXO6;P4HB;XBP1;CRYAB;SAR1A;HSPH1;DNAJB2;LMAN1;ERP29;SEC13;RNF185;SSR1;SVIP;VCP;OS9;YOD1;UBXN6;UBE2D2A;STT3A;UBQLN1;SEC61B;TRAF2;DNAJC1;DERL1;DERL2;SSR4;HSP90B1;UBQLN4;TUSC3;SEC63;MAN1A;DNAJB11
gsea,Salmonella infection,-0.46131974730012404,-1.7678524876627197,0.0019646365422396855,0.01347557551937114,0.253,15/54,7.35%,ACTB;PFN2;RAC1;ACTG1;JUN;CDC42;ARPC5;WASL;ARPC5L;ARPC2;IL18;IFNGR2;ARPC1A;ARPC3;PFN1
gsea,Mitophagy,-0.44213804365129394,-1.7615248590544832,0.004081632653061225,0.0141120736883023,0.267,25/58,25.90%,UBB;GABARAPL1;JUN;BNIP3L;GABARAPL2;SQSTM1;GABARAP;TOMM7;KRAS;CITED2;PINK1;HRAS;CSNK2B;RAB7;TBK1;ATG9A;FUNDC1;USP30;FIS1;NRAS;MRAS;CSNK2A1;FOXO3;RELA;MFN2
gsea,Salivary secretion,-0.45154292575707533,-1.7513301626359121,0.001984126984126984,0.015638760010638613,0.291,9/51,2.55%,CALM1;ATP1B1;CALM2;CALM3;GNAS;VAMP2;CST3;ATP1A1;ATP1A3
gsea,Vasopressin-regulated water reabsorption,-0.4912024317959275,-1.745797199157496,0.00404040404040404,0.016087657552009194,0.304,19/36,22.35%,GNAS;DYNLL1;VAMP2;DYNLL2;ARHGDIA;DCTN6;RAB11A;AQP4;PRKACB;NSF;CREB3L2;DCTN5;STX4A;CREB1;RAB5A;RAB11B;RAB5B;RAB5C;PRKACA
gsea,Renin secretion,-0.47142776308914186,-1.7407531220152597,0.00202020202020202,0.016717819253355172,0.317,9/43,5.45%,CALM1;CALM2;CALM3;GNAS;PPP3CA;KCNJ2;CTSB;PPP3R1;PPP3CB
gsea,Tuberculosis,-0.4073855515971084,-1.7229731620967919,0.005415162454873646,0.019001056301487823,0.351,46/101,30.61%,CALM1;CALM2;ATP6V0C;CALM3;PPP3CA;ATP6V0B;BAX;PPP3R1;CYCS;IL18;PPP3CB;IFNGR2;LAMP1;NFYB;BAD;CEBPB;MAPK3;HSPD1;LAMP2;BCL10;HSPA9;IRAK4;CAMK2B;CREB1;MAPK1;RAB5A;RAB7;RAB5B;RHOA;RAB5C;IL10RA;IL10RB;TGFB2;CTSD;JAK1;AKT1;RELA;SPHK2;H2-DMA;CTSS;CORO1A;AKT3;ATP6AP1;ATP6V0D1;FCGR3;RIPK2
gsea,cGMP-PKG signaling pathway,-0.38036651283621564,-1.7026917090599165,0.0018726591760299626,0.022502276824213054,0.4,31/117,13.02%,CALM1;ATP1B1;CALM2;SLC25A4;CALM3;PPP3CA;ATP1A1;SLC25A5;VDAC1;ATP1A3;RGS2;MEF2C;PPP3R1;ATP1B2;PPP1CA;PPP3CB;IRS2;VDAC3;BAD;GNAI1;ATP1A2;ADRB1;MYLK3;ADRA2C;ATP2B1;GNAI2;VDAC2;SLC8A2;ATF2;GNA11;MAPK3
gsea,Viral carcinogenesis,-0.3792485220427488,-1.6983071693532554,0.0,0.022947880650531438,0.411,47/133,25.39%,YWHAG;RAC1;YWHAH;YWHAB;JUN;UBE3A;PKM;YWHAE;CDC42;SNW1;BAX;NFKB2;YWHAZ;YWHAQ;KRAS;VDAC3;CDK4;BAD;RANBP1;HRAS;DNAJA3;TBPL1;HNRNPK;PSMC1;LYN;PIK3R1;ATF2;MAPK3;H2-M5;GTF2B;CDKN1B;EGR3;PRKACB;CREB3L2;CCND3;CREB1;MAPK1;NFKBIA;IRF3;RHOA;NRAS;PRKACA;TRAF2;JAK1;HDAC10;GTF2H4;RELA
gsea,Human immunodeficiency virus 1 infection,-0.3722369595959759,-1.6969393830013448,0.0,0.0227265426951408,0.416,31/148,13.76%,CALM1;CALM2;CALM3;RAC1;PPP3CA;JUN;CFL1;CALR;ELOB;GNB2;GNG2;BAX;PDIA3;PPP3R1;CYCS;CFL2;PPP3CB;KRAS;RBX1;GNG13;BAD;GNG10;HRAS;RNF7;GNG3;GNAI1;GNAI2;PIK3R1;GNA11;MAPK3;H2-M5
gsea,Glucagon signaling pathway,-0.4130712399177679,-1.687484153712943,0.00390625,0.02417454869208574,0.437,16/74,11.29%,CALM1;CALM2;CALM3;GNAS;PPP3CA;PGAM1;PKM;PPP3R1;PPP3CB;LDHA;PHKG1;G6PC3;LDHB;PPP4C;PGAM2;PFKL
gsea,Mucin type O-glycan biosynthesis,0.5383141463061586,1.6830241356279725,0.0042643923240938165,0.0800872885979269,0.408,10/21,22.87%,GALNT18;GALNT14;GALNTL6;GALNT10;GALNT16;GALNT7;GALNT3;ST3GAL2;GALNT11;GALNT12
gsea,Synaptic vesicle cycle,-0.4313455600748255,-1.6762171533346633,0.007766990291262136,0.02624191022193327,0.468,22/62,17.47%,ATP6V0C;RAB3A;CPLX2;ATP6V1D;VAMP2;ATP6V1A;ATP6V1G2;ATP6V0E2;CLTA;ATP6V0B;AP2M1;ATP6V1F;ATP6V1E1;SNAP25;AP2B1;ATP6V1C1;SLC18A2;ATP6V1B2;NSF;CLTB;ATP6V1G1;AP2S1
gsea,Carbohydrate digestion and absorption,-0.5134194002263897,-1.67026994684657,0.019120458891013385,0.026835356619671423,0.479,17/26,32.13%,ATP1B1;ATP1A1;ATP1A3;ATP1B2;LCT;G6PC3;ATP1A2;PIK3R1;HK1;AKT1;PIK3CB;HK2;AKT3;PIK3R2;ATP1A4;FXYD2;PRKCB
gsea,Neuroactive ligand-receptor interaction,0.3598329166233064,1.6646828588018623,0.0,0.07692307692307691,0.443,25/138,8.77%,GRIK4;GRIA3;GRIN2A;GRIA1;GRIN1;GABRA2;GRIA4;GABRG3;GABBR2;CHRNA4;CHRM3;GRM8;GRIK5;TRHR;GRIK2;RXFP1;GRID2;GRM7;HTR2C;GRID1;ADCYAP1R1;CHRNA7;GRIK1;THRB;GABRB1
gsea,Metabolism of xenobiotics by cytochrome P450,-0.5371633509210436,-1.6578264891980365,0.01486988847583643,0.028823546795118057,0.508,8/20,22.22%,GSTM5;GSTM1;GSTP1;HPGDS;CBR1;ADH5;GSTO1;GSTM7
gsea,Endocrine and other factor-regulated calcium reabsorption,-0.47113456331362635,-1.649812396535153,0.012605042016806723,0.030260941517184312,0.529,18/36,22.35%,ATP1B1;GNAS;ATP1A1;CLTA;ATP1A3;AP2M1;CALB1;ATP1B2;RAB11A;ATP1A2;ATP2B1;AP2B1;PRKACB;CLTB;AP2S1;PLCB1;AP2A2;PRKACA
gsea,Aldosterone-regulated sodium reabsorption,-0.4865147706651936,-1.6251581903301515,0.013861386138613862,0.03587121823476326,0.579,8/27,13.02%,ATP1B1;ATP1A1;ATP1A3;ATP1B2;KRAS;ATP1A2;PIK3R1;MAPK3
gsea,Human cytomegalovirus infection,-0.35044808089717666,-1.6049095653926548,0.0037593984962406013,0.042152991942422134,0.644,32/158,13.76%,CALM1;CALM2;CALM3;GNAS;RAC1;PPP3CA;CALR;GNB2;GNG2;RHEB;BAX;PDIA3;PPP3R1;CYCS;PPP3CB;KRAS;GNG13;ITGAV;CDK4;GNG10;HRAS;GNG3;GNAI1;CX3CL1;GSK3B;GNAI2;PIK3R1;ATF2;GNA11;MAPK3;ARHGEF1;H2-M5
gsea,RNA degradation,-0.38863510015895114,-1.6042195062443756,0.011673151750972763,0.0415825264077281,0.645,22/68,19.44%,PABPC4;TOB1;BTG2;ENO2;ZCCHC7;C1D;LSM7;LSM4;LSM2;PABPC1;PFKL;EXOSC4;EXOSC3;LSM8;HSPD1;LSM1;CNOT8;HSPA9;BTG1;ENO1;LSM5;CNOT6L
gsea,Hippo signaling pathway,-0.37032184565213677,-1.6026481682814406,0.0038314176245210726,0.04152282600227279,0.652,29/114,19.37%,ACTB;YWHAG;YWHAH;ACTG1;YWHAB;YWHAE;CTNNA3;CSNK1E;PPP1CA;YWHAZ;PPP2CA;PPP2R1A;YWHAQ;FZD3;FZD2;WWTR1;FZD4;CTNNA1;GSK3B;WNT16;ID2;SMAD2;SMAD7;PPP1CC;BMPR2;LIMD1;CCND3;BMP6;BMPR1B
gsea,Bile secretion,-0.44117969838023996,-1.5954012991323165,0.01782178217821782,0.04331434988369295,0.672,12/36,17.14%,ATP1B1;GNAS;ATP1A1;NCEH1;ATP1A3;ATP1B2;AQP4;ATP1A2;LDLR;HMGCR;PRKACB;CAR2
gsea,Cellular senescence,-0.354616538549786,-1.590628600785257,0.005555555555555556,0.04439598656797435,0.681,22/119,13.76%,CALM1;CALM2;SLC25A4;CALM3;PPP3CA;SLC25A5;VDAC1;RHEB;SQSTM1;PPP3R1;PPP1CA;PPP3CB;KRAS;VDAC3;CDK4;HRAS;VDAC2;PIK3R1;MAPK3;ZFP36L1;HIPK1;H2-M5
gsea,Oxytocin signaling pathway,-0.35902287547367134,-1.58196161464072,0.01532567049808429,0.04654087153060486,0.695,19/117,6.94%,CALM1;CALM2;ACTB;KCNJ3;CALM3;GNAS;PPP3CA;MYL6;ACTG1;JUN;RGS2;EEF2;MEF2C;KCNJ2;PPP3R1;PPP1CA;PPP3CB;KRAS;KCNJ4
gsea,Circadian entrainment,0.3845957703326884,1.580210820637727,0.008281573498964804,0.13553113553113555,0.657,24/78,9.93%,RYR2;PRKG1;CACNA1C;GRIA3;GRIN2A;GRIA1;GRIN1;GUCY1A2;GRIA4;ADCY8;NOS1AP;ADCY2;RYR3;KCNJ6;PRKCG;CAMK2A;NOS1;ADCY9;CAMK2G;ADCYAP1R1;GNAO1;CACNA1H;ADCY6;PER3
gsea,Long-term depression,0.4097532473202595,1.5773588707975001,0.008064516129032258,0.12159028914348062,0.664,13/50,9.35%,PRKG1;GRIA3;GRIA1;CACNA1A;GUCY1A2;RAF1;PRKCG;PLA2G4E;NOS1;GRID2;GNA12;IGF1R;GNAO1
gsea,Fructose and mannose metabolism,-0.4912251376164874,-1.5771744034048651,0.023255813953488372,0.047314777202716145,0.707,10/25,24.40%,ALDOA;PMM1;ALDOC;TPI1;PFKL;GMPPB;PFKFB3;HK1;TKFC;PFKFB1
gsea,RNA polymerase,-0.46560106536349993,-1.5641432506974133,0.03333333333333333,0.051514524660894234,0.733,14/26,31.07%,POLR2F;POLR2I;POLR2G;POLR2E;POLR2C;POLR3H;POLR3D;POLR2J;POLR2B;POLR2L;POLR3E;POLR3A;POLR1D;POLR2D
gsea,Glycosphingolipid biosynthesis,0.4442965405116471,1.5608801131663232,0.019417475728155338,0.1257804449293811,0.706,7/32,8.36%,ST6GALNAC3;ST6GALNAC5;ST3GAL3;HEXA;SEC1;HEXB;GCNT2
gsea,Hypertrophic cardiomyopathy (HCM),0.3896884355326529,1.5601455193078182,0.012987012987012988,0.11402073104200762,0.709,11/57,7.76%,RYR2;CACNA1C;CACNA2D3;CACNB2;SLC8A1;PRKAG2;DMD;CACNG3;SGCD;ITGA8;ITGA3
gsea,Apoptosis,-0.35532559872548397,-1.5571657803064685,0.009596928982725527,0.05387904828021213,0.748,40/101,29.68%,ACTB;TUBA4A;TUBA1A;ACTG1;JUN;BAX;CTSB;CYCS;KRAS;BOK;BAD;HRAS;PARP1;TUBA1B;CTSO;PIK3R1;MAPK3;CTSH;DFFB;MAPK1;NFKBIA;PARP4;NRAS;BBC3;ENDOG;CFLAR;DIABLO;DAXX;TRAF2;HTRA2;CTSD;AKT1;RELA;PIK3CB;CTSS;AKT3;PIK3R2;CTSL;MAP2K1;CTSZ
gsea,Apelin signaling pathway,-0.3504013894730083,-1.539952324014218,0.007518796992481203,0.060788801621339754,0.793,26/102,16.04%,CALM1;CALM2;CALM3;GABARAPL1;RPS6;GNB2;GNG2;GABARAPL2;MEF2C;GABARAP;EGR1;KRAS;GNG13;GNG10;HRAS;GNG3;GNAI1;MYLK3;GNAI2;SLC8A2;ADCY10;MAPK3;JAG1;TFAM;SMAD2;PRKACB
gsea,SNARE interactions in vesicular transport,-0.4368577064746659,-1.53397418682322,0.02131782945736434,0.06268337885702466,0.805,10/28,19.10%,VAMP2;STX7;BET1L;STX16;VTI1B;GOSR1;SNAP29;VAMP3;STX4A;USE1
gsea,Retrograde endocannabinoid signaling,-0.339040238742045,-1.5252970464382807,0.0041753653444676405,0.06602588728981354,0.819,44/117,18.95%,KCNJ3;NDUFA3;NDUFS5;NDUFA1;GABRG2;GNB2;NDUFA4;GNG2;NDUFS8;NDUFS2;NDUFB3;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;NDUFB8;GNG13;NDUFC2;NDUFV2;NDUFA7;NDUFA8;GNG10;GNG3;GNAI1;NDUFC1;NDUFV1;NDUFB6;NDUFA5;GNAI2;MAPK3;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;GRM1;NDUFB7;PRKACB;NDUFB2;NDUFAB1;DAGLB;NDUFA10;NDUFA11
gsea,C-type lectin receptor signaling pathway,-0.37226725925754217,-1.5135026028054985,0.020872865275142316,0.07107684124144421,0.839,9/71,6.43%,CALM1;CALM2;CALM3;PPP3CA;JUN;NFKB2;PPP3R1;PPP3CB;KRAS
gsea,Morphine addiction,0.359466629643529,1.5132611839193537,0.018367346938775512,0.14938253236125576,0.811,20/76,10.17%,PDE2A;CACNA1A;GABRA2;PDE1A;GABRG3;GABBR2;ADCY8;CACNA1B;ADCY2;KCNJ6;PDE7B;PRKCG;PDE10A;ADCY9;PDE4A;GRK3;GABRB1;GNAO1;ADCY6;GRK5
gsea,Melanogenesis,-0.37796002540879003,-1.5085218946513568,0.02099236641221374,0.07326672559096685,0.849,23/69,23.13%,CALM1;CALM2;CALM3;GNAS;KRAS;FZD3;FZD2;HRAS;GNAI1;FZD4;GSK3B;GNAI2;MAPK3;WNT16;PRKACB;CAMK2B;CREB3L2;CREB1;MAPK1;PLCB1;NRAS;PRKACA;A
gsea,Neurotrophin signaling pathway,-0.344216203663288,-1.5067321204586377,0.008113590263691683,0.0731470752858245,0.851,20/106,13.02%,CALM1;CALM2;CALM3;BEX3;RAC1;JUN;ARHGDIA;MAGED1;YWHAE;CDC42;BDNF;BAX;KRAS;BAD;HRAS;NFKBIB;GSK3B;PIK3R1;RAP1A;MAPK3
gsea,Arrhythmogenic right ventricular cardiomyopathy (ARVC),0.37831236702328724,1.506290308577055,0.025,0.14493544280778323,0.822,11/56,7.76%,RYR2;CACNA1C;CACNA2D3;CACNB2;SLC8A1;DMD;ACTN2;CACNG3;SGCD;ITGA8;ITGA3
gsea,p53 signaling pathway,-0.39081399924675164,-1.5029913729521052,0.02185792349726776,0.0739696451883747,0.86,15/51,23.07%,RPRM;SESN1;CD82;COP1;BAX;CYCS;PPM1D;CDK4;DDB2;SIVA1;CCND3;SESN3;RRM2B;BBC3;CCNG2
gsea,HIF-1 signaling pathway,-0.36697070140759913,-1.5017430412425394,0.009940357852882704,0.07380216035780685,0.864,23/74,19.64%,GAPDH;ALDOA;RPS6;ELOB;IFNGR2;TRF;PGK1;RBX1;ENO2;LDHA;PFKL;EPO;TEK;ANGPT2;PIK3R1;MAPK3;CDKN1B;CAMK2B;ENO1;PFKFB3;HK1;ELOC;MAPK1
gsea,Cell cycle,-0.3377785638274665,-1.495563518130897,0.013133208255159476,0.07665880028538499,0.878,19/93,15.51%,YWHAG;YWHAH;YWHAB;YWHAE;STAG1;SMC1A;YWHAZ;YWHAQ;ANAPC13;RBX1;PCNA;CDK4;RAD21;ORC1;ANAPC11;GSK3B;CDKN1B;SMAD2;CDC45
gsea,Thyroid hormone synthesis,-0.39515135746863495,-1.4879736415424532,0.041666666666666664,0.08023411606492883,0.887,7/46,5.02%,ATP1B1;TTR;GNAS;ATP1A1;ATP1A3;CANX;ATP1B2
gsea,Epstein-Barr virus infection,-0.32554473579450566,-1.4831043882727042,0.019197207678883072,0.08187791207383985,0.892,44/132,25.39%,RAC1;JUN;CALR;PSMC3;PSMC2;SNW1;SEM1;BAX;NFKB2;PDIA3;CYCS;PSMD2;PSMD4;PSMC5;PSMD7;CDK4;NFKBIB;ADRM1;PSMC6;PSMD6;PSMC1;LYN;PIK3R1;DDB2;PSMC4;H2-M5;CDKN1B;ENTPD1;IRAK4;CD247;CCND3;NFKBIA;TBK1;IRF3;VIM;TRAF2;CIR1;JAK1;MAVS;SIN3A;AKT1;PSMD11;B2M;RELA
gsea,Hepatitis C,-0.34334833625363403,-1.4754273173299928,0.021568627450980392,0.08524491680386617,0.899,33/96,26.16%,YWHAG;YWHAH;YWHAB;YWHAE;CD81;BAX;CYCS;YWHAZ;PPP2CA;PPP2R1A;YWHAQ;KRAS;CDK4;BAD;HRAS;GSK3B;PIK3R1;LDLR;MAPK3;PSME3;CLDN10;MAPK1;NFKBIA;TBK1;IRF3;NRAS;CFLAR;TRAF2;JAK1;MAVS;AKT1;RELA;PIK3CB
gsea,Calcium signaling pathway,0.31705512500337746,1.467742763526761,0.009237875288683603,0.18041042427294476,0.886,35/132,12.05%,RYR2;CACNA1C;GRIN2A;CACNA1E;GRIN1;CACNA1A;PDE1A;SLC8A1;ATP2B4;PHKG2;ADCY8;CACNA1B;ATP2B3;ADCY2;RYR3;PRKCG;CHRM3;CAMK2A;TRHR;NOS1;MCU;HTR2C;ADCY9;PLCG2;CAMK2G;ITPKB;CHRNA7;PHKA1;PLCE1;CACNA1H;ERBB4;CAMK1G;PLCG1;ORAI1;TNNC1
gsea,Endocytosis,-0.3072308872305984,-1.4625384310840326,0.008016032064128256,0.09237382422169206,0.906,67/210,23.80%,UBB;HSPA8;ARF1;FGFR2;CLTA;CAPZA2;VPS29;CDC42;AP2M1;ARPC5;WASL;ARPC5L;HSPA2;ARPC2;SH3GLB1;ARPC1A;ARF3;VPS28;ARPC3;CHMP4B;CYTH2;RAB11A;EHD3;ARF5;SNX3;PML;HRAS;EPN1;RAB22A;CHMP2A;TSG101;RAB31;CHMP6;AP2B1;ACAP2;LDLR;STAM2;ARFGAP2;H2-M5;VPS4A;ARPC4;SNX5;CYTH4;RUFY1;SMAD2;CHMP4C;CLTB;VPS35;AP2S1;CHMP7;RAB11FIP2;EHD1;SH3GL2;SNX4;RAB5A;EPS15;RAB7;RAB11B;AP2A2;RAB5B;RHOA;RAB5C;VPS26B;ARPC1B;SMAP1;RAB35;ARF6
gsea,Dilated cardiomyopathy (DCM),0.3586098929500466,1.462408743066707,0.031578947368421054,0.17379783337230145,0.89,13/62,7.76%,RYR2;CACNA1C;CACNA2D3;CACNB2;SLC8A1;ADCY8;ADCY2;DMD;CACNG3;ADCY9;SGCD;ITGA8;ITGA3
gsea,Amyotrophic lateral sclerosis (ALS),-0.39524605981791316,-1.4602810653869633,0.038,0.0929767428115488,0.909,9/43,5.45%,NEFL;RAC1;PPP3CA;NEFM;BAX;SOD1;PPP3R1;CYCS;PPP3CB
gsea,Renal cell carcinoma,-0.35825019047317136,-1.4592479730166168,0.030828516377649325,0.09249993389751159,0.91,28/61,29.48%,RAC1;JUN;ELOB;CDC42;KRAS;RBX1;BAD;HRAS;PIK3R1;RAP1A;MAPK3;ARNT2;PDGFB;ELOC;MAPK1;NRAS;TGFB2;PAK2;PTPN11;AKT1;PIK3CB;RAP1B;EPAS1;GAB1;AKT3;SLC2A1;PIK3R2;MAP2K1
gsea,PI3K-Akt signaling pathway,-0.30643623071266457,-1.4522127330786645,0.0076481835564053535,0.09621726717385573,0.918,53/224,19.83%,HSP90AB1;YWHAG;RAC1;YWHAH;HSP90AA1;YWHAB;RPS6;GNB2;FGFR2;YWHAE;GNG2;BDNF;RHEB;VEGFC;YWHAZ;CDC37;PPP2CA;PPP2R1A;YWHAQ;PDGFA;KRAS;GNG13;VTN;ITGAV;FGFR1;CDK4;BAD;GNG10;HRAS;G6PC3;GNG3;VEGFB;COL4A5;EPO;GSK3B;TEK;ANGPT2;PIK3R1;ATF2;MAPK3;PPP2R5D;EPOR;CDKN1B;ITGA2B;COL1A2;CREB3L2;CCND3;CSF1R;PDGFB;CREB1;PDGFD;MAPK1;PPP2R5A
gsea,Arginine and proline metabolism,-0.39600978480100213,-1.448362586600385,0.05168986083499006,0.09763881911404002,0.922,21/38,38.80%,CKB;SRM;GOT2;ODC1;CKMT1;PYCRL;ARG2;SMS;MAOB;LAP3;ALDH2;CKMT2;SMOX;GAMT;SAT1;ALDH9A1;AMD1;GOT1;PYCR1;OAT;ALDH1B1
gsea,Protein digestion and absorption,-0.3944353989550805,-1.4461806818678478,0.052158273381294966,0.0976777226187595,0.924,10/42,12.64%,ATP1B1;ATP1A1;ATP1A3;ATP1B2;SLC38A2;SLC3A1;KCNJ13;ATP1A2;COL4A5;SLC8A2
gsea,Pentose phosphate pathway,-0.45044657986404535,-1.444457977573078,0.0546875,0.09794615680132392,0.926,3/23,11.29%,ALDOA;ALDOC;PFKL
gsea,Rap1 signaling pathway,-0.3140535562640278,-1.4397656544847521,0.020522388059701493,0.09990663851593548,0.931,26/150,13.02%,CALM1;CALM2;ACTB;CALM3;GNAS;PFN2;RAC1;ACTG1;FGFR2;CDC42;VEGFC;PRKD1;PDGFA;KRAS;PFN1;FGFR1;HRAS;GNAI1;RALA;VEGFB;TEK;ANGPT2;GNAI2;PIK3R1;RAP1A;MAPK3
gsea,Chemical carcinogenesis,-0.4478939892246829,-1.4369471009839119,0.06382978723404255,0.10052191186529615,0.931,7/23,17.39%,GSTM5;GSTM1;GSTP1;HPGDS;CBR1;ADH5;GSTO1
gsea,Dopaminergic synapse,-0.3265905007655825,-1.436209143172194,0.03434343434343434,0.09973805799752691,0.931,23/106,12.95%,CALM1;CALM2;KCNJ3;CALM3;CALY;GNAS;PPP3CA;GNB2;GNG2;PPP1CA;PPP2CA;PPP3CB;PPP2R1A;GNG13;COMT;GNG10;GNG3;GNAI1;GSK3B;GNAI2;PPP1R1B;SLC18A2;ATF2
gsea,Lysosome,-0.32788429279423126,-1.4356943684039305,0.027422303473491772,0.09883777382816952,0.931,48/109,34.96%,ATP6V0C;LAPTM4A;PSAP;CLTA;ATP6V0B;CTSB;ARSA;LAMP1;FUCA1;AGA;CTSO;CD63;GUSB;DNASE2A;LAPTM5;LAMP2;AP3S2;CLTB;CTSH;AP3M1;CLN5;AP3M2;ACP2;CTSD;LIPA;GBA;GNPTG;HYAL1;GM2A;AP1M1;M6PR;CTSS;CTSL;AP1S1;SMPD1;CTSZ;ATP6AP1;AP1S2;ATP6V0D1;CTNS;AP4B1;LITAF;CTSF;LGMN;NAGA;NAGPA;TPP1;ARSG
gsea,Viral myocarditis,-0.43085819194014374,-1.4302693177952852,0.06909090909090909,0.10122952458266915,0.937,4/31,4.82%,ACTB;RAC1;ACTG1;CYCS
gsea,Base excision repair,-0.43227901133412605,-1.4289724893701656,0.05913978494623656,0.10109155735400943,0.937,12/27,31.63%,HMGB1;PCNA;MPG;PARP1;APEX1;TDG;PARP4;POLD4;POLD2;POLL;POLD3;FEN1
gsea,Biosynthesis of unsaturated fatty acids,-0.42015870017825035,-1.41594577838591,0.08266129032258064,0.10954917352045335,0.95,8/27,20.47%,TECR;SCP2;HACD4;SCD1;SCD2;ACOX1;ACOT3;HSD17B12
gsea,Leukocyte transendothelial migration,-0.3543691599749436,-1.4158561633656552,0.03088803088803089,0.10838489209599468,0.95,22/70,21.27%,ACTB;RAC1;ACTG1;CDC42;CTNNA3;MYL12B;GNAI1;NCF2;CTNNA1;GNAI2;EZR;PIK3R1;RAP1A;VCL;JAM2;VASP;MYL9;CLDN10;MYL12A;THY1;RHOA;CXCL12
gsea,MAPK signaling pathway,0.27967138771421346,1.4094439549604256,0.009324009324009324,0.23164211674849974,0.942,47/226,11.48%,CACNA1C;CACNA1E;CACNA1A;CACNA2D3;FLNB;CACNB2;TAOK1;RPS6KA2;FGF10;PTPRR;CHUK;MAPK10;CACNA1B;TGFBR1;MAPK14;NF1;RAF1;PRKCG;MAP4K4;MAPT;FLT3;PLA2G4E;MAP3K2;NTF3;FLNA;RASGRF2;PTPN5;MAP3K7;CACNG3;NTRK2;SOS1;GNA12;MAPKAPK2;EFNA1;IKBKB;MAP3K4;AKT2;MAP3K5;IGF1R;RPS6KA6;CACNA1H;RASGRF1;ERBB4;IL1R1;MAP3K3;STK4;MAPK12
gsea,Human T-cell leukemia virus 1 infection,-0.3060739187566484,-1.4082146337455566,0.030534351145038167,0.11301632880882408,0.957,58/147,29.48%,SLC25A4;PPP3CA;JUN;RAN;CALR;SLC25A5;VDAC1;ETS2;BAX;CANX;NFKB2;PPP3R1;PPP3CB;EGR1;KRAS;GPS2;FDPS;NFYB;VDAC3;CDK4;RANBP1;HRAS;TBPL1;ANAPC11;VDAC2;PIK3R1;ATF2;MAPK3;H2-M5;ELK4;SMAD2;PRKACB;CREB3L2;CCND3;TLN1;IL1R2;CREB1;MAPK1;NFKBIA;NRAS;PRKACA;TGFB2;JAK1;AKT1;B2M;CDC26;CDC16;RELA;PIK3CB;H2-DMA;PTEN;CREB3;BUB3;AKT3;SLC2A1;PIK3R2;KAT5;MAP2K1
gsea,Autophagy,-0.30781364492801416,-1.400037433901536,0.02529182879377432,0.11804919373109922,0.963,46/120,29.48%,HMGB1;GABARAPL1;GABARAPL2;RHEB;GABARAP;RRAGA;CTSB;PPP2CA;SH3GLB1;LAMP1;KRAS;IRS2;ATG12;RRAGD;BAD;HRAS;PIK3R1;MAPK3;SNAP29;LAMP2;PRKACB;AKT1S1;NRBF2;ATG3;MAPK1;RAB7;ATG9A;NRAS;CFLAR;PRKACA;DDIT4;ATG10;CTSD;MRAS;AKT1;PIK3CB;TRP53INP2;RPS6KB1;RRAGC;PTEN;AKT3;PIK3R2;STK11;CTSL;IGBP1;MAP2K1
gsea,Cholinergic synapse,0.3261210687930036,1.398388523258222,0.03571428571428571,0.23472449536279322,0.949,23/84,10.19%,CACNA1C;CACNA1A;ADCY8;CACNA1B;CHRNA4;ADCY2;KCNJ6;PRKCG;CHRM3;CAMK2A;KCNQ2;KCNQ3;KCNQ5;ADCY9;JAK2;CAMK2G;PIK3R3;CHRNA7;AKT2;GNAO1;ADCY6;PIK3CD;FYN
gsea,Aldosterone synthesis and secretion,-0.33951348908661094,-1.3978359169931958,0.04093567251461988,0.11863806278534847,0.965,9/75,5.73%,CALM1;ATP1B1;CALM2;CALM3;GNAS;ATP1A1;ATP1A3;ATP1B2;PRKD1
gsea,Gap junction,-0.3391013173914055,-1.396031603649556,0.058365758754863814,0.11878241853688244,0.965,28/70,22.35%,TUBA4A;GNAS;TUBB2A;TUBA1A;TUBB5;TUBB2B;TUBB4A;PDGFA;KRAS;TUBB4B;HRAS;GNAI1;ADRB1;TUBA1B;GJA1;GNAI2;GNA11;MAPK3;GRM1;PRKACB;PDGFB;HTR2A;PDGFD;MAPK1;TUBB3;PLCB1;NRAS;PRKACA
gsea,mTOR signaling pathway,-0.29958381892187624,-1.3915705609255387,0.03327495621716287,0.12075396874574003,0.968,49/125,30.02%,ATP6V1D;ATP6V1A;RPS6;ATP6V1G2;LAMTOR2;RHEB;ATP6V1F;RRAGA;LAMTOR3;KRAS;FZD3;ATP6V1E1;FZD2;RRAGD;HRAS;FZD4;GSK3B;ATP6V1C1;PIK3R1;MAPK3;SEH1L;WNT16;SEC13;ATP6V1B2;AKT1S1;ATP6V1G1;TBC1D7;TTI1;MAPK1;RHOA;NRAS;DDIT4;CAB39;DVL1;AKT1;GRB10;LAMTOR1;PIK3CB;CAB39L;FNIP2;RPS6KB1;RRAGC;PTEN;AKT3;LAMTOR5;PIK3R2;STK11;MAP2K1;FZD6
gsea,Cocaine addiction,-0.375285031167235,-1.3903866202872561,0.06464646464646465,0.12057093885753126,0.969,18/40,25.39%,GNAS;JUN;GRM3;BDNF;CDK5R1;GNAI1;GNAI2;PPP1R1B;SLC18A2;ATF2;PRKACB;CREB3L2;CREB1;MAOB;PRKACA;GRM2;PDYN;RELA
gsea,Influenza A,-0.31847344020143153,-1.3895584199416455,0.03929273084479371,0.12016779144587139,0.969,34/92,29.48%,ACTB;ACTG1;HSPA8;JUN;VDAC1;HSPA2;CYCS;IL18;IFNGR2;FDPS;PML;NFKBIB;GSK3B;PIK3R1;ATF2;MAPK3;IVNS1ABP;IRAK4;MAPK1;DDX39B;NFKBIA;TBK1;IRF3;JAK1;MAVS;AKT1;HNRNPUL1;RELA;PIK3CB;H2-DMA;AKT3;NLRX1;PIK3R2;MAP2K1
gsea,Glioma,-0.346143512200904,-1.3835402763373679,0.05642023346303502,0.12392505688702385,0.97,11/65,13.02%,CALM1;CALM2;CALM3;BAX;PDGFA;KRAS;CDK4;HRAS;PIK3R1;DDB2;MAPK3
gsea,Amphetamine addiction,-0.36187560169666805,-1.379992274994888,0.07243460764587525,0.1254844422482081,0.973,9/54,5.45%,CALM1;CALM2;CALM3;GNAS;PPP3CA;JUN;PPP3R1;PPP1CA;PPP3CB
gsea,Axon guidance,0.29367102376075105,1.3786311484754472,0.026156941649899398,0.25108308462501205,0.964,40/157,10.80%,SLIT1;PLXNA4;SLIT3;PAK3;NRP1;SEMA5B;ABLIM3;ABLIM2;NTNG2;EPHB1;PLXNC1;ROCK1;RAF1;SRGAP2;TRPC5;CAMK2A;PLXNA2;DCC;LIMK2;TRPC6;TRPC3;SEMA4D;PTK2;PLCG2;CAMK2G;SSH3;PIK3R3;EFNA1;SSH2;PLXNA3;SRGAP3;EPHB2;NCK2;UNC5A;PIK3CD;EFNB2;FYN;NEO1;EPHA6;SMO
gsea,Regulation of actin cytoskeleton,-0.29932579474809423,-1.3777346325786692,0.04183266932270916,0.1260132765538616,0.973,41/161,19.64%,ACTB;TMSB4X;PFN2;RAC1;ACTG1;CFL1;FGFR2;BRK1;CDC42;ARPC5;WASL;ARPC5L;MYL12B;ARPC2;CFL2;PPP1CA;ARPC1A;PDGFA;KRAS;ARPC3;PIP4K2A;PFN1;ITGAV;FGFR1;HRAS;MYLK3;EZR;PIK3R1;MAPK3;VCL;ARHGEF1;ARPC4;PPP1CC;MYH14;MYL9;ITGA2B;RDX;PDGFB;PDGFD;MYL12A;MAPK1
gsea,B cell receptor signaling pathway,-0.3685061195571535,-1.371723393059754,0.08143939393939394,0.12946868728658972,0.975,25/53,29.48%,RAC1;PPP3CA;JUN;CD81;PPP3R1;PPP3CB;KRAS;HRAS;NFKBIB;GSK3B;LYN;PIK3R1;MAPK3;BCL10;MAPK1;NFKBIA;NRAS;AKT1;RELA;INPPL1;PIK3CB;PIK3AP1;AKT3;PIK3R2;MAP2K1
gsea,Hedgehog signaling pathway,0.3741081229061286,1.3664285515376284,0.07421875,0.25595562829605384,0.97,13/38,14.06%,CSNK1G1;LRP2;CDON;SUFU;CCND2;GRK3;GPR161;SMO;SMURF2;EVC2;BTRC;GRK2;EVC
gsea,"Glycine, serine and threonine metabolism",-0.41093743384542464,-1.3655076924607314,0.1,0.1331245013150507,0.976,9/28,26.48%,PGAM1;PHGDH;PGAM2;MAOB;PSAT1;PSPH;CHDH;GRHPR;GAMT
gsea,Inflammatory bowel disease (IBD),-0.45866159862543066,-1.3650937277373634,0.11394891944990176,0.13207328002518626,0.976,8/17,27.16%,JUN;IL18;IFNGR2;MAF;SMAD2;TGFB2;RELA;H2-DMA
gsea,TGF-beta signaling pathway,-0.34579874979856706,-1.3643162823231478,0.06540084388185655,0.13140424466722178,0.976,25/59,26.94%,PPP2CA;PPP2R1A;RBX1;INHBA;BAMBI;MAPK3;ID4;ID2;SMAD2;SMAD7;BMPR2;ID3;NBL1;E2F4;BMP6;BMPR1B;MAPK1;RHOA;SMAD9;TGFB2;FST;SMAD5;LTBP1;BMPR1A;RPS6KB1
gsea,Adrenergic signaling in cardiomyocytes,-0.30517777145265934,-1.3629634511986422,0.04024144869215292,0.13121643694283927,0.976,27/111,16.93%,CALM1;ATP1B1;CALM2;CALM3;GNAS;PPP1R1A;ATP1A1;ATP1A3;ATP1B2;PPP1CA;TPM1;PPP2CA;PPP2R1A;GNAI1;SCN1B;ATP1A2;ADRB1;ATP2B1;GNAI2;ATF2;MAPK3;PPP2R5D;PPP1CC;PRKACB;CAMK2B;CACNA2D4;CREB3L2
gsea,Glycerolipid metabolism,0.36360381040252304,1.3574690669308713,0.0880503144654088,0.2568122433743934,0.981,15/41,20.27%,DGKG;DGKH;PLPP4;DGKQ;DGKB;MBOAT2;DGKI;LPIN1;PNPLA2;DGAT1;LPIN2;MGLL;DGKA;ALDH7A1;MBOAT1
gsea,Tight junction,-0.30368024761287127,-1.3502784247257698,0.04198473282442748,0.14135715048862602,0.983,27/113,19.52%,ACTB;TUBA4A;RAC1;TUBA1A;MYL6;ACTG1;JUN;CDC42;WASL;MYL12B;PPP2CA;PPP2R1A;ACTR2;PCNA;CDK4;TUBA1B;EZR;RAP1A;JAM2;VASP;PRKACB;MYH14;MYL9;CLDN10;SYNPO;RDX;MYL12A
gsea,GnRH signaling pathway,-0.3298586270571839,-1.3464654828680536,0.06782945736434108,0.1437800002533003,0.985,8/69,6.43%,CALM1;CALM2;CALM3;GNAS;JUN;CDC42;EGR1;KRAS
gsea,NOD-like receptor signaling pathway,-0.3100626726908362,-1.3436640507634892,0.06483300589390963,0.14493938277091242,0.985,28/95,23.94%,HSP90AB1;GABARAPL1;HSP90AA1;JUN;VDAC1;GABARAPL2;GABARAP;CTSB;IL18;ATG12;VDAC3;NFKBIB;ERBIN;VDAC2;MAPK3;SHARPIN;IRAK4;TXN1;MAPK1;NFKBIA;TBK1;IRF3;PLCB1;RHOA;TRAF2;JAK1;P2RX7;MAVS
gsea,DNA replication,-0.394936822677519,-1.3397994438836665,0.1014760147601476,0.14684599117370795,0.985,12/31,31.92%,PCNA;RPA3;RNASEH1;RNASEH2C;RFC3;MCM6;RNASEH2A;POLD4;POLD2;POLD3;FEN1;RFC5
gsea,Glyoxylate and dicarboxylate metabolism,-0.39843652697937093,-1.338048394660603,0.10625,0.1471017990418682,0.986,4/25,5.47%,MDH2;MDH1;MCEE;GLUL
gsea,ABC transporters,0.38445956413315446,1.3362997924719717,0.08875739644970414,0.2800872885979269,0.985,9/31,19.10%,ABCC5;ABCA5;ABCB1B;ABCA3;ABCB8;ABCA4;ABCA8B;ABCD4;ABCC8
gsea,Phospholipase D signaling pathway,0.3013684690559209,1.3325889372090345,0.06493506493506493,0.2729067622684644,0.985,28/115,11.53%,DGKG;ADCY8;ADCY2;RAF1;DNM1;DGKH;GRM8;DNM3;PLA2G4E;PIP5K1B;RAPGEF4;SOS1;GRM7;DGKQ;ADCY9;GNA12;PLCG2;GAB2;DGKB;PIK3R3;DGKI;AKT2;ADCY6;PIK3CD;DNM2;FYN;MTOR;PLCG1
gsea,Choline metabolism in cancer,0.3076884048573641,1.3319104579686143,0.04627766599597585,0.2618161979864107,0.985,20/84,11.53%,DGKG;SLC44A5;MAPK10;RAF1;DGKH;PRKCG;PLA2G4E;PIP5K1B;CHKA;SOS1;DGKQ;DGKB;PIK3R3;SLC22A4;DGKI;SP1;AKT2;PIK3CD;MTOR;PLCG1
gsea,Cytosolic DNA-sensing pathway,-0.3763492266617048,-1.3311325343768368,0.08316831683168317,0.15225903773697955,0.987,15/33,28.99%,POLR2F;IL18;POLR2E;NFKBIB;POLR3H;POLR3D;NFKBIA;TBK1;IRF3;POLR2L;MAVS;POLR3E;RELA;POLR3A;POLR1D
gsea,Progesterone-mediated oocyte maturation,0.32000812214891317,1.3309730488758673,0.07142857142857142,0.2522118646077943,0.985,20/68,11.48%,RPS6KA2;ADCY8;MAPK10;CDC27;ADCY2;MAPK14;RAF1;STK10;MAD1L1;ADCY9;PIK3R3;AKT2;ANAPC5;CPEB1;IGF1R;RPS6KA6;ADCY6;PIK3CD;CPEB4;MAPK12
gsea,Prolactin signaling pathway,0.34151551040429745,1.3308637453629788,0.07024793388429752,0.24186215675577377,0.985,13/51,11.48%,GCK;MAPK10;MAPK14;RAF1;SOS1;CCND2;JAK2;PIK3R3;AKT2;SOCS2;PIK3CD;SOCS7;MAPK12
gsea,GABAergic synapse,0.31954323847863886,1.3262986239458012,0.08617234468937876,0.2390398254228041,0.986,16/73,9.46%,CACNA1C;CACNA1A;GABRA2;GABRG3;GABBR2;ADCY8;CACNA1B;ADCY2;KCNJ6;PRKCG;SLC6A1;ADCY9;GABRB1;TRAK2;GNAO1;ADCY6
gsea,ErbB signaling pathway,0.3168905323500187,1.3261588570396008,0.08757637474541752,0.23011876285198707,0.986,20/75,11.53%,PAK3;MAPK10;NRG1;RAF1;PRKCG;CAMK2A;CBL;ABL2;SOS1;PTK2;PLCG2;CAMK2G;PIK3R3;AKT2;NCK2;PIK3CD;ERBB4;MTOR;NRG2;PLCG1
gsea,Lysine degradation,0.3322005036099964,1.3227938762310025,0.07039337474120083,0.2265058293427088,0.986,18/53,21.08%,EHMT1;KMT2A;ACAT1;NSD1;SETDB1;COLGALT2;KMT2C;NSD3;EHMT2;KMT2B;KMT5B;KMT2E;SETMAR;CAMKMT;ALDH7A1;EZH2;DHTKD1;SETD2
gsea,Prostate cancer,-0.32106128050029137,-1.321051965940377,0.08565737051792828,0.16005630942242546,0.989,31/76,29.48%,HSP90AB1;HSP90AA1;FGFR2;GSTP1;PDGFA;KRAS;FGFR1;BAD;HRAS;GSK3B;PIK3R1;MAPK3;CDKN1B;CREB3L2;PDGFB;IL1R2;CREB1;PDGFD;MAPK1;NFKBIA;NRAS;HSP90B1;AKT1;RELA;PIK3CB;TCF7L1;PTEN;CREB3;AKT3;PIK3R2;MAP2K1
gsea,Long-term potentiation,-0.34390081269041173,-1.3181570315975408,0.10655737704918032,0.1614002075008606,0.989,9/57,6.43%,CALM1;CALM2;CALM3;PPP1R1A;PPP3CA;PPP3R1;PPP1CA;PPP3CB;KRAS
gsea,PPAR signaling pathway,-0.36117569921155024,-1.316444084517228,0.10609037328094302,0.16165624617411015,0.989,13/43,17.72%,ACSL3;FABP5;DBI;SCP2;FABP3;SCD1;PLTP;ILK;FABP7;SCD2;ACOX1;ACSBG1;UBC
gsea,Adherens junction,-0.32521487478589667,-1.3151215455225005,0.07660455486542443,0.16169435329764292,0.989,12/61,13.08%,ACTB;RAC1;ACTG1;ACP1;CDC42;CTNNA3;WASL;FGFR1;CSNK2B;CTNNA1;MAPK3;VCL
gsea,Insulin secretion,0.32014919616130705,1.300090111249448,0.09919028340080972,0.2509352349777882,0.991,18/61,9.46%,RYR2;CACNA1C;GCK;ADCY8;PCLO;KCNN3;ADCY2;PRKCG;CHRM3;CAMK2A;KCNMA1;RAPGEF4;ADCY9;CAMK2G;ADCYAP1R1;STX1A;KCNMB4;ADCY6
gsea,Central carbon metabolism in cancer,-0.32918773461793993,-1.2945750061590562,0.11553784860557768,0.1818145055300564,0.992,25/52,29.48%,PGAM1;PKM;FGFR2;KRAS;LDHA;FGFR1;HRAS;PGAM2;SCO2;PFKL;PIK3R1;MAPK3;SIRT6;HK1;MAPK1;NRAS;AKT1;PIK3CB;HK2;PTEN;GLS;AKT3;SLC2A1;PIK3R2;MAP2K1
gsea,cAMP signaling pathway,-0.27502548403869903,-1.2935698722387399,0.06179775280898876,0.18131895664508535,0.992,35/147,16.93%,CALM1;ATP1B1;CALM2;CALM3;GNAS;RAC1;JUN;ATP1A1;NPY1R;ATP1A3;BDNF;ATP1B2;PPP1CA;BAD;HHIP;GNAI1;ATP1A2;ADRB1;SOX9;GABBR1;ATP2B1;GNAI2;PPP1R1B;PIK3R1;RAP1A;ADCY10;MAPK3;SSTR2;FXYD1;ACOX1;PPP1CC;PRKACB;MYL9;CAMK2B;CREB3L2
gsea,Glycerophospholipid metabolism,0.30479779389214084,1.290024345672925,0.06772009029345373,0.25699343454295764,0.993,23/74,20.35%,DGKG;DGKH;PLPP4;PLA2G4E;PCYT2;CHKA;DGKQ;DGKB;MBOAT2;DGKI;ETNK1;LPIN1;ETNK2;PNPLA6;CHKB;PGS1;LPIN2;LYPLA2;CDS1;DGKA;PLA2G3;MBOAT1;PLA2G4A
gsea,Pyruvate metabolism,-0.3691338877606838,-1.2864271112979742,0.13409961685823754,0.18694609667889836,0.995,8/32,9.94%,MDH2;PKM;MDH1;GLO1;DLAT;LDHA;HAGH;LDHB
gsea,Measles,-0.30173112002964364,-1.2849650724968675,0.07561436672967864,0.18700922391929808,0.995,27/83,26.16%,RACK1;HSPA8;JUN;EIF3H;HSPA2;BAX;CYCS;CDK4;BAD;NFKBIB;CSNK2B;GSK3B;PIK3R1;CDKN1B;IRAK4;CCND3;RAB9;NFKBIA;TBK1;IRF3;BBC3;JAK1;MAVS;AKT1;CSNK2A1;RELA;PIK3CB
gsea,Olfactory transduction,-0.3770083186740648,-1.2779635959349283,0.16798418972332016,0.1937549743275861,0.995,5/32,3.81%,CALM1;CALM2;CALM3;RGS2;NCALD
gsea,ECM-receptor interaction,0.3408963373602584,1.2598822468199218,0.16593886462882096,0.2954900891071104,0.995,17/46,19.72%,THBS3;LAMB1;TNR;LAMC1;LAMB3;SV2B;ITGA8;ITGA3;RELN;COL4A1;COL9A2;ITGB8;ITGA4;COL4A4;ITGA1;COL4A2;CD44
gsea,Pathways in cancer,-0.24768050770233016,-1.242303530173325,0.07312614259597806,0.23477659038437326,0.998,54/360,13.35%,CALM1;CALM2;HSP90AB1;CALM3;GNAS;RAC1;HSP90AA1;JUN;RASGRP1;GSTM5;ELOB;GNB2;FGFR2;CDC42;GNG2;CTNNA3;GSTM1;BAX;VEGFC;NFKB2;CYCS;GSTP1;IFNGR2;PDGFA;KRAS;RBX1;GNG13;FZD3;FZD2;ITGAV;FGFR1;CDK4;BAD;GNG10;HHIP;PML;HRAS;GNG3;GNAI1;RALA;VEGFB;COL4A5;FZD4;EPO;CTNNA1;GSK3B;CKS2;GNAI2;PIK3R1;DDB2;GNA11;CEBPA;MAPK3;ARHGEF1
gsea,Th17 cell differentiation,-0.3113383124691141,-1.242153233117573,0.1417910447761194,0.2330565324034398,0.998,7/57,5.94%,HSP90AB1;PPP3CA;HSP90AA1;JUN;PPP3R1;PPP3CB;IFNGR2
gsea,Peroxisome,-0.29439500482849373,-1.2381012674508765,0.12109375,0.236218222457876,0.998,19/71,26.88%,ACSL3;PRDX5;SOD1;MPV17;SCP2;PRDX1;PAOX;PEX12;ACOX1;NUDT19;PEX19;NUDT7;PEX11B;IDH2;FAR2;GNPAT;MPV17L;SLC25A17;PEX5
gsea,Ras signaling pathway,-0.2608050520430989,-1.2344008657725773,0.09057971014492754,0.23904903596054414,0.998,30/169,13.02%,CALM1;CALM2;CALM3;RAC1;RASGRP1;RASAL2;GNB2;FGFR2;CDC42;GNG2;BDNF;ETS2;VEGFC;PDGFA;KRAS;GNG13;FGFR1;BAD;GNG10;HRAS;GNG3;RASA1;RALA;VEGFB;TEK;ANGPT2;FOXO4;PIK3R1;RAP1A;MAPK3
gsea,Thyroid hormone signaling pathway,-0.2856819660438707,-1.2329462519595211,0.11974789915966387,0.23901992145013798,0.998,17/102,13.21%,ATP1B1;ACTB;ACTG1;ATP1A1;ATP1A3;RHEB;ATP1B2;KRAS;ITGAV;MED4;BAD;HRAS;ATP1A2;GSK3B;PIK3R1;MAPK3;DIO2
gsea,Systemic lupus erythematosus,-0.43799129574584444,-1.2232090111067944,0.21333333333333335,0.25006458476524035,0.998,2/16,0.23%,H3F3B;H3F3A
gsea,Ribosome biogenesis in eukaryotes,-0.2925848482920078,-1.2231745984646811,0.12380952380952381,0.24808676379325628,0.998,27/72,29.93%,RAN;POP5;SNU13;NOP10;EMG1;EIF6;CSNK2B;GAR1;FBLL1;FCF1;DKC1;IMP3;NHP2;LSG1;MPHOSPH10;RPP38;POP4;RPP25L;GTPBP4;RRP7A;CSNK2A1;WDR75;PWP2;XRN1;FBL;NOL6;SPATA5
gsea,Starch and sucrose metabolism,0.3886411420992381,1.2079459520373883,0.2092511013215859,0.3799341815814019,0.999,5/20,12.75%,GCK;PGM2L1;AGL;PYGB;AMY1
gsea,Complement and coagulation cascades,-0.3968506956979603,-1.20700553122093,0.23476702508960573,0.2687459806168988,0.998,10/23,34.35%,VTN;MASP2;CLU;C1QB;CD59A;CFH;PROS1;C1QC;F2RL2;SERPINC1
gsea,Inflammatory mediator regulation of TRP channels,0.3000531942047644,1.1999607779534358,0.17819706498951782,0.3825184124386252,0.999,21/66,11.53%,ASIC2;ADCY8;PRKCE;MAPK10;ADCY2;MAPK14;PRKCG;CAMK2A;PLA2G4E;CYP2J6;HTR2C;ADCY9;ASIC4;PLCG2;CAMK2G;PIK3R3;ADCY6;PIK3CD;IL1R1;MAPK12;PLCG1
gsea,Transcriptional misregulation in cancer,-0.2719321979173909,-1.1901837404499085,0.13636363636363635,0.2907663965982502,0.998,25/109,19.90%,DDX5;H3F3B;H3F3A;TSPAN7;MEF2C;BAX;EYA1;PDGFA;PML;CEBPB;MAF;DDB2;CEBPA;ETV1;EWSR1;WNT16;ID2;ELK4;CDKN1B;SS18;BMP2K;CSF1R;ARNT2;IL1R2;PBX1
gsea,IL-17 signaling pathway,-0.30918977240903556,-1.1819781735116557,0.20342205323193915,0.30069594255149384,0.998,16/48,25.39%,HSP90AB1;HSP90AA1;JUN;JUND;CEBPB;GSK3B;MAPK6;MAPK3;IL17RB;MAPK1;NFKBIA;TBK1;TRAF3IP2;TRAF2;HSP90B1;RELA
gsea,Vascular smooth muscle contraction,0.27708795774286,1.1802248080038333,0.16808510638297872,0.4104547934335168,0.999,14/81,6.93%,PRKG1;CACNA1C;GUCY1A2;ADCY8;PRKCE;ROCK1;ADCY2;RAF1;PRKCG;PLA2G4E;PPP1R12B;KCNMA1;ADCY9;GNA12
gsea,Human papillomavirus infection,-0.2443631345275796,-1.1794626367388001,0.14814814814814814,0.30227953572216454,0.998,51/234,20.33%,ATP6V0C;GNAS;ATP6V1D;ATP6V1A;UBE3A;ATP6V1G2;PKM;ATP6V0E2;CDC42;ATP6V0B;RHEB;ATP6V1F;BAX;PPP2CA;PPP2R1A;KRAS;FZD3;VTN;ATP6V1E1;FZD2;ITGAV;CDK4;BAD;HRAS;TBPL1;COL4A5;FZD4;GSK3B;PSMC1;ATP6V1C1;PIK3R1;MAPK3;H2-M5;PPP2R5D;WNT16;JAG1;CDKN1B;PRKACB;ATP6V1B2;HEY1;ATP6V1G1;ITGA2B;COL1A2;CREB3L2;CCND3;TADA3;CREB1;MAPK1;PPP2R5A;TBK1;IRF3
gsea,Fc epsilon RI signaling pathway,0.3083727713113142,1.1782988251266968,0.23503325942350334,0.4025063380507686,0.999,13/51,11.53%,MAPK10;MAPK14;RAF1;PLA2G4E;SOS1;PLCG2;GAB2;PIK3R3;AKT2;PIK3CD;FYN;MAPK12;PLCG1
gsea,Chagas disease (American trypanosomiasis),-0.28830353897858396,-1.1706321755220457,0.2058252427184466,0.31403001088866506,0.999,23/62,26.16%,GNAS;JUN;CALR;PPP2CA;PPP2R1A;IFNGR2;GNAI1;GNAI2;PIK3R1;GNA11;MAPK3;SMAD2;C1QB;IRAK4;CD247;MAPK1;NFKBIA;PLCB1;CFLAR;TGFB2;AKT1;RELA;PIK3CB
gsea,Purine metabolism,0.25831430051742477,1.1680984650572739,0.16447368421052633,0.41122281973345803,0.999,15/104,9.46%,PDE2A;GUCY1A2;AK5;PDE1A;PDE9A;ADCY8;ADCY2;PDE7B;PDE10A;AK9;PFAS;ADCY9;PDE4A;PDE6H;ADCY6
gsea,Mismatch repair,-0.37460225657492313,-1.1670168471753137,0.2600732600732601,0.31700357485344277,0.999,10/21,32.49%,PCNA;RPA3;RFC3;POLD4;POLD2;MLH1;MLH3;POLD3;RFC5;MSH6
gsea,Chemokine signaling pathway,-0.2646467618774739,-1.1659675486709964,0.17450980392156862,0.3162031974940158,1.0,45/113,29.48%,RAC1;GNB2;CDC42;GNG2;WASL;KRAS;GNG13;CCL27A;BAD;GNG10;HRAS;NFKBIB;GNG3;GNAI1;CX3CL1;GSK3B;GNAI2;LYN;PIK3R1;RAP1A;MAPK3;PRKACB;HCK;DOCK2;MAPK1;RASGRP2;NFKBIA;CXCR6;PLCB1;RHOA;CXCL12;NRAS;PRKACA;AKT1;FOXO3;RELA;GNG7;PIK3CB;CXCL14;RAP1B;GNG11;AKT3;CCR5;PIK3R2;MAP2K1
gsea,Nucleotide excision repair,-0.3234216555516849,-1.1651132426924673,0.21631878557874762,0.3152655420281843,1.0,19/41,35.71%,CETN2;RBX1;PCNA;RPA3;GTF2H5;DDB2;RFC3;ERCC3;GTF2H4;POLD4;POLD2;POLD3;GTF2H3;XPA;RFC5;RAD23B;ERCC1;RAD23A;CCNH
gsea,Fc gamma R-mediated phagocytosis,-0.2936312943036874,-1.160352743447346,0.2376237623762376,0.3208838340288275,1.0,32/74,29.48%,RAC1;CFL1;CDC42;ARPC5;WASL;ARPC5L;MARCKSL1;ARPC2;MARCKS;CFL2;ARPC1A;ARPC3;LYN;PIK3R1;MAPK3;ARPC4;VASP;HCK;PLPP3;DOCK2;MAPK1;ARPC1B;ARF6;AKT1;INPPL1;PIK3CB;SPHK2;RPS6KB1;WASF1;AKT3;PIK3R2;MAP2K1
gsea,Pancreatic secretion,-0.29544532086091985,-1.153335359572319,0.23921568627450981,0.3299598425222705,1.0,11/54,12.89%,ATP1B1;GNAS;RAC1;ATP1A1;ATP1A3;ATP1B2;CCK;RAB11A;ATP1A2;ATP2B1;RAP1A
gsea,Proteoglycans in cancer,-0.2487954112583925,-1.143481136521059,0.20224719101123595,0.34375233588810683,1.0,29/141,16.82%,ACTB;DDX5;RAC1;ACTG1;RPS6;CDC42;TIMP3;PPP1CA;KRAS;FZD3;VTN;FZD2;ITGAV;FGFR1;HRAS;FZD4;CD63;EZR;PIK3R1;MAPK3;ARHGEF1;WNT16;ANK1;SMAD2;PPP1CC;GPC1;PRKACB;CAMK2B;COL1A2
gsea,Insulin signaling pathway,-0.2546165283891552,-1.1414142100546238,0.21923076923076923,0.34460820592487873,1.0,16/112,13.02%,CALM1;CALM2;CALM3;RPS6;RHEB;PPP1CA;KRAS;IRS2;BAD;HRAS;PHKG1;G6PC3;GSK3B;PRKAR1B;PIK3R1;MAPK3
gsea,Melanoma,-0.291101393449681,-1.1406960792785135,0.23728813559322035,0.34339590156456984,1.0,21/51,29.66%,BAX;PDGFA;KRAS;FGFR1;CDK4;BAD;HRAS;PIK3R1;DDB2;MAPK3;PDGFB;PDGFD;MAPK1;NRAS;AKT1;PIK3CB;PTEN;AKT3;PIK3R2;MAP2K1;FGF5
gsea,Steroid biosynthesis,-0.38509133104949617,-1.1361269314022675,0.2780952380952381,0.34822193369746407,1.0,6/15,23.68%,MSMO1;SQLE;EBP;HSD17B7;FDFT1;LIPA
gsea,T cell receptor signaling pathway,-0.27749560123708317,-1.1358684634889813,0.25190839694656486,0.34603859452111474,1.0,21/70,21.64%,PPP3CA;JUN;RASGRP1;CDC42;NCK1;PPP3R1;PPP3CB;KRAS;CDK4;HRAS;NFKBIB;GSK3B;PIK3R1;MAPK3;MAP3K8;BCL10;CD247;MAPK1;NFKBIA;RHOA;NRAS
gsea,Pyrimidine metabolism,-0.293954398565411,-1.1356248834542375,0.23984526112185686,0.3439767660756536,1.0,13/46,21.42%,NME7;NME2;DTYMK;UCKL1;NME4;TK2;DUT;NME1;ENTPD1;NT5C1A;RRM1;RRM2B;CAD
gsea,Ubiquitin mediated proteolysis,0.24684978877054006,1.1293345201432152,0.23265306122448978,0.48242104625083343,0.999,13/122,4.48%,UBE2E2;UBR5;PRKN;HUWE1;TRIP12;HERC2;BIRC6;CDC27;HERC1;UBE3C;CBL;UBE4A;PIAS2
gsea,Ovarian steroidogenesis,0.33439643325426666,1.1239047170117142,0.2563559322033898,0.48123737485439616,0.999,7/27,9.46%,ADCY8;ADCY2;PLA2G4E;CYP2J6;ADCY9;IGF1R;ADCY6
gsea,Terpenoid backbone biosynthesis,-0.3602192835626086,-1.1221163678906156,0.31237322515212984,0.36350090257553475,1.0,4/20,14.19%,HMGCS1;FDPS;PCYOX1;HMGCR
gsea,Endometrial cancer,-0.289539717179405,-1.122089333501265,0.28225806451612906,0.3610085354817764,1.0,22/51,29.48%,CTNNA3;BAX;KRAS;BAD;HRAS;CTNNA1;GSK3B;PIK3R1;DDB2;MAPK3;ILK;MAPK1;NRAS;AKT1;FOXO3;PIK3CB;TCF7L1;PTEN;AKT3;MLH1;PIK3R2;MAP2K1
gsea,Leishmaniasis,-0.3124471740728466,-1.1203782907359443,0.27037037037037037,0.36144685126629034,1.0,13/35,27.16%,JUN;MARCKSL1;IFNGR2;NFKBIB;NCF2;MAPK3;IRAK4;MAPK1;NFKBIA;TGFB2;JAK1;RELA;H2-DMA
gsea,RIG-I-like receptor signaling pathway,0.3043118317998574,1.1150403547167278,0.28627450980392155,0.4875671174663335,0.999,11/35,19.23%,CHUK;MAPK10;MAPK14;TRAF3;MAP3K7;IKBKB;MAPK12;MAPK11;SIKE1;NFKB1;AZI2
gsea,Fatty acid elongation,-0.3312235483052114,-1.114452993199443,0.28600823045267487,0.3690693558034955,1.0,16/27,46.18%,TECR;HACD4;ACOT3;HSD17B12;ACOT2;THEM4;ELOVL4;HADH;ACAA2;PPT1;ACOT1;ELOVL2;ACOT4;ACOT5;ECHS1;ELOVL7
gsea,Platelet activation,-0.26564014210850506,-1.1081643875743408,0.2807971014492754,0.37676232376762325,1.0,26/86,21.21%,ACTB;GNAS;ACTG1;RASGRP1;P2RY12;MYL12B;PPP1CA;GNAI1;MYLK3;GNAI2;LYN;PIK3R1;RAP1A;MAPK3;ARHGEF1;VASP;PPP1CC;PRKACB;ITGA2B;COL1A2;TLN1;MYL12A;MAPK1;RASGRP2;PLCB1;RHOA
gsea,Hepatocellular carcinoma,-0.24508309667104608,-1.1074388280298488,0.26515151515151514,0.3752221654641939,1.0,43/128,30.02%,ACTB;ACTG1;GSTM5;GSTM1;BAX;GSTP1;KRAS;FZD3;FZD2;CDK4;BAD;BRD7;HRAS;FZD4;GSK3B;PIK3R1;DDB2;MAPK3;WNT16;SMARCE1;SMAD2;GSTO1;ACTL6B;MAPK1;SMARCB1;TXNRD1;CSNK1A1;NRAS;GSTM7;TGFB2;DVL1;AKT1;KEAP1;PIK3CB;TCF7L1;RPS6KB1;PTEN;GAB1;AKT3;PIK3R2;GSTO2;MAP2K1;FZD6
gsea,Cytokine-cytokine receptor interaction,-0.26683005346295596,-1.1027835266995596,0.2888086642599278,0.38041185486440954,1.0,28/81,26.47%,IL18;IFNGR2;CCL27A;INHBA;CX3CL1;EPO;EPOR;BMPR2;IL17RB;IL27;CSF1R;CD27;ACKR4;IL1R2;TNFSF12;BMP6;BMPR1B;CRLF2;IL11RA1;CXCR6;CXCL12;IL10RA;IL10RB;TGFB2;IL13RA1;TNFRSF9;CXCL14;BMPR1A
gsea,Thyroid cancer,-0.33579137902875367,-1.1026269002725462,0.3087378640776699,0.3780586753975745,1.0,10/27,29.48%,BAX;KRAS;HRAS;DDB2;MAPK3;MAPK1;NRAS;TCF7L1;RXRB;MAP2K1
gsea,Porphyrin and chlorophyll metabolism,-0.35034697263520365,-1.092654359866388,0.33089579524680074,0.39277756434882827,1.0,6/21,27.59%,HMOX2;GUSB;ALAD;FXN;COX15;FECH
gsea,Insulin resistance,0.2581047132390073,1.090711860188876,0.2874493927125506,0.5301243582749312,1.0,14/80,10.86%,RPS6KA2;PRKAG2;PRKCE;MAPK10;PPARGC1B;PTPRF;PIK3R3;SLC27A3;IKBKB;AKT2;RPS6KA6;PIK3CD;PYGB;MTOR
gsea,VEGF signaling pathway,-0.2867530158171261,-1.0888726659520522,0.33084112149532713,0.39645152571908,1.0,10/47,13.02%,RAC1;PPP3CA;CDC42;PPP3R1;PPP3CB;KRAS;BAD;HRAS;PIK3R1;MAPK3
gsea,Regulation of lipolysis in adipocytes,0.2833946533937045,1.0852115581680153,0.29350104821802936,0.5303873431533006,1.0,10/39,12.16%,PRKG1;ADCY8;ADCY2;ADCY9;PIK3R3;AKT2;ADCY6;PIK3CD;PNPLA2;PRKG2
gsea,NF-kappa B signaling pathway,0.26736454324705106,1.0789794080252426,0.3340961098398169,0.5322475483347305,1.0,11/56,11.53%,CHUK;TRAF3;LCK;MAP3K7;CSNK2A2;PLCG2;IKBKB;LBP;ERC1;IL1R1;PLCG1
gsea,MicroRNAs in cancer,0.24122890173840256,1.069370447078902,0.3413173652694611,0.5424622658665211,1.0,20/109,12.18%,PRKCE;APC;RPTOR;ROCK1;NOTCH2;ZEB1;RAF1;PRKCG;TNR;DICER1;SOS1;ABCB1B;CCND2;PLCG2;IKBKB;TRIM71;MTOR;MMP16;PLCG1;RECK
gsea,AMPK signaling pathway,-0.24716270545954613,-1.0652098842691264,0.35135135135135137,0.4353152155485496,1.0,34/96,29.12%,RAB2A;EEF2;RHEB;PPP2CA;PPP2R1A;RAB14;IRS2;G6PC3;PFKL;PIK3R1;SCD1;PPP2R5D;HMGCR;SCD2;ADIPOR2;AKT1S1;CREB3L2;PFKFB3;CREB1;PPP2R5A;RAB11B;FASN;CAB39;PFKFB1;AKT1;FOXO3;PIK3CB;CAB39L;CPT1C;RPS6KB1;CREB3;AKT3;PIK3R2;STK11
gsea,Inositol phosphate metabolism,0.25839063245501265,1.0625412971300332,0.33820459290187893,0.5465052842588716,1.0,17/67,14.77%,IPPK;OCRL;PIP5K1B;SYNJ1;PIKFYVE;INPP5A;PLCG2;MTMR7;ITPKB;PLCH1;MTMR1;PLCE1;PIK3CD;PLCG1;INPP5B;ITPKC;INPP5K
gsea,Focal adhesion,0.22917234611183712,1.0613957056181322,0.3094262295081967,0.5366760898675792,1.0,28/147,10.19%,PAK3;FLNB;MAPK10;ROCK1;RAF1;THBS3;LAMB1;PRKCG;TNR;PPP1R12B;TLN2;FLNA;LAMC1;SOS1;PTK2;CCND2;LAMB3;ACTN4;ITGA8;PIK3R3;ITGA3;AKT2;PARVB;IGF1R;RELN;PIK3CD;RASGRF1;FYN
gsea,Mannose type O-glycan biosynthesis,0.33806536395542297,1.0602205964801097,0.35119047619047616,0.5274292295568891,1.0,5/20,13.16%,MGAT5B;ST3GAL3;LARGE1;B3GALNT2;CHST10
gsea,Chronic myeloid leukemia,0.25590605142627526,1.0601553903858492,0.3559670781893004,0.5160819753789226,1.0,13/67,11.09%,CHUK;TGFBR1;RAF1;BCR;CBL;SOS1;HDAC1;GAB2;PIK3R3;IKBKB;AKT2;PIK3CD;POLK
gsea,Fatty acid degradation,-0.3069573822208075,-1.058318737568063,0.3685220729366603,0.4458760601672626,1.0,17/33,38.97%,ACSL3;ACOX1;ACSBG1;ADH5;ALDH2;CPT1C;EHHADH;GCDH;ACADVL;ALDH9A1;HADH;ACOX3;ECI1;ACSL6;ACAA2;ALDH1B1;ACAT2
gsea,Serotonergic synapse,-0.2514656862683796,-1.0578864862088724,0.3523809523809524,0.4438005329284622,1.0,14/78,13.02%,KCNJ3;GNAS;GNB2;GNG2;KCND2;KRAS;GNG13;GNG10;HRAS;GNG3;GNAI1;GNAI2;SLC18A2;MAPK3
gsea,One carbon pool by folate,-0.344206588483656,-1.0574237137553917,0.375,0.44171518070864985,1.0,4/18,18.29%,DHFR;ATIC;ALDH1L1;MTHFD2
gsea,AGE-RAGE signaling pathway in diabetic complications,-0.25839498070360434,-1.0552944710435939,0.37937743190661477,0.44246624854798855,1.0,16/72,16.82%,RAC1;JUN;CDC42;BAX;VEGFC;EGR1;KRAS;CDK4;HRAS;VEGFB;COL4A5;PIK3R1;MAPK3;CDKN1B;SMAD2;COL1A2
gsea,Relaxin signaling pathway,-0.24413208532610575,-1.0515899171466316,0.36381709741550694,0.4471921460990908,1.0,36/95,29.48%,GNAS;JUN;GNB2;GNG2;VEGFC;KRAS;GNG13;GNG10;HRAS;GNG3;GNAI1;VEGFB;COL4A5;GNAI2;PIK3R1;ATF2;MAPK3;SMAD2;PRKACB;COL1A2;CREB3L2;CREB1;MAPK1;NFKBIA;PLCB1;NRAS;PRKACA;AKT1;RELA;GNG7;PIK3CB;CREB3;GNG11;AKT3;PIK3R2;MAP2K1
gsea,Osteoclast differentiation,-0.24709799339885477,-1.0358994008440208,0.37316176470588236,0.47344068954965834,1.0,10/86,5.94%,RAC1;PPP3CA;JUN;JUND;SQSTM1;NFKB2;PPP3R1;JUNB;PPP3CB;IFNGR2
gsea,Phosphatidylinositol signaling system,-0.24268342962910663,-1.0303301779899,0.40643863179074446,0.4810615416954982,1.0,12/88,13.29%,CALM1;CALM2;CALM3;CDIPT;PIP4K2A;INPP5F;ITPKA;CDS2;INPP4B;PIP4P1;PIK3R1;IMPA1
gsea,"Parathyroid hormone synthesis, secretion and action",-0.249119857412345,-1.0296042760380528,0.36507936507936506,0.4794645231833092,1.0,20/73,22.35%,GNAS;NACA;JUND;MEF2C;EGR1;FGFR1;GNAI1;GNAI2;ATF2;GNA11;MAPK3;ARHGEF1;NR4A2;PRKACB;CREB3L2;CREB1;MAPK1;PLCB1;RHOA;PRKACA
gsea,Propanoate metabolism,-0.304081724439326,-1.0255730683265654,0.39960629921259844,0.4843806413232995,1.0,6/27,15.07%,MCEE;ALDH6A1;LDHA;LDHB;SUCLG1;DBT
gsea,Natural killer cell mediated cytotoxicity,-0.26718449539797073,-1.0251322593598562,0.4264432029795158,0.4823100236085253,1.0,9/56,13.02%,RAC1;PPP3CA;PPP3R1;PPP3CB;IFNGR2;KRAS;HRAS;PIK3R1;MAPK3
gsea,Wnt signaling pathway,-0.23027170565539648,-1.0206285533253576,0.41776937618147447,0.48787936089280215,1.0,26/109,22.35%,RAC1;PPP3CA;JUN;CACYBP;CSNK1E;PPP3R1;PPP3CB;TBL1XR1;RBX1;FZD3;FZD2;CSNK2B;RUVBL1;BAMBI;FZD4;GSK3B;TBL1X;WNT16;PRKACB;CAMK2B;CCND3;CSNK1A1;PLCB1;RHOA;VANGL2;PRKACA
gsea,Homologous recombination,-0.290013121985655,-1.0161802147747179,0.43796992481203006,0.4932596895341571,1.0,15/36,33.43%,SEM1;RPA3;BABAM2;SYCP3;XRCC2;UIMC1;RAD50;RBBP8;RAD51;POLD4;POLD2;PALB2;POLD3;MUS81;XRCC3
gsea,Small cell lung cancer,0.2451748419960972,1.0118148659677655,0.4375,0.6182168518067115,1.0,13/70,11.09%,RARB;CHUK;LAMB1;TRAF3;LAMC1;PTK2;LAMB3;PIK3R3;ITGA3;IKBKB;AKT2;PIK3CD;POLK
gsea,Acute myeloid leukemia,0.2574015317069318,1.0070627738392868,0.4457593688362919,0.6168621567557737,1.0,11/51,10.86%,CHUK;RAF1;FLT3;SOS1;PIK3R3;IKBKB;RUNX1T1;AKT2;PIK3CD;PPARD;MTOR
gsea,"Alanine, aspartate and glutamate metabolism",-0.28860380239985167,-1.0017132416688277,0.4358974358974359,0.518106864322769,1.0,14/30,37.95%,GLUL;NIT2;GOT2;NAT8L;CAD;ALDH5A1;GLUD1;GLS;GPT;GFPT2;IL4I1;ADSSL1;ASPA;GOT1
gsea,Sphingolipid signaling pathway,0.22289130863390302,0.9890704611810458,0.46487603305785125,0.6469376621352305,1.0,17/100,10.19%,PRKCE;MAPK10;ROCK1;MAPK14;RAF1;PRKCG;CERS4;SGMS1;GNA12;CERS6;GAB2;PPP2R2B;PIK3R3;AKT2;MAP3K5;PIK3CD;FYN
gsea,Longevity regulating pathway,0.22559266105696432,0.9877778685079752,0.4895397489539749,0.6373158756137479,1.0,18/86,11.71%,PRKAG2;ADCY8;RB1CC1;RPTOR;EHMT1;ADCY2;HDAC1;ADCY9;PIK3R3;AKT2;IGF1R;EHMT2;ADCY6;PIK3CD;MTOR;KL;CLPB;ADIPOR1
gsea,Colorectal cancer,-0.23063905432448933,-0.978569545746932,0.5166340508806262,0.5610351213061708,1.0,26/74,29.48%,RAC1;JUN;BAX;CYCS;KRAS;BAD;HRAS;RALA;GSK3B;PIK3R1;DDB2;MAPK3;SMAD2;MAPK1;RHOA;NRAS;BBC3;TGFB2;AKT1;PIK3CB;TCF7L1;RPS6KB1;AKT3;MLH1;PIK3R2;MAP2K1
gsea,mRNA surveillance pathway,-0.22925004055692064,-0.9783226391866835,0.5111940298507462,0.5581682758776899,1.0,19/81,21.65%,PABPC4;WDR82;CPSF2;SAP18;PPP1CA;PPP2CA;PPP2R1A;RBM8A;MAGOH;PABPC1;MAGOHB;PPP2R5D;UPF3A;PPP1CC;DDX39B;PPP2R5A;UPF2;SSU72;NCBP2
gsea,Non-small cell lung cancer,0.24572904554464878,0.9782489263823617,0.49156118143459915,0.6478931998331248,1.0,12/57,11.53%,RARB;RAF1;PRKCG;EML4;SOS1;PLCG2;PIK3R3;AKT2;PIK3CD;POLK;STK4;PLCG1
gsea,Toll-like receptor signaling pathway,0.2448772557922079,0.976759976469269,0.4805194805194805,0.6389168660036091,1.0,11/54,11.48%,CHUK;MAPK10;MAPK14;TRAF3;MAP3K7;PIK3R3;IKBKB;AKT2;PIK3CD;LBP;MAPK12
gsea,Cell adhesion molecules (CAMs),0.24047270669611115,0.9725610639597273,0.4775510204081633,0.6363524071271963,1.0,11/73,10.64%,NLGN1;NTNG2;CNTNAP2;NEGR1;PTPRF;NECTIN1;NFASC;ITGA8;ALCAM;CADM1;NEO1
gsea,Pancreatic cancer,-0.23136639800937536,-0.9633682221581888,0.5087378640776699,0.5854023041883203,1.0,22/66,29.48%,RAC1;CDC42;BAX;KRAS;CDK4;BAD;RALA;PIK3R1;DDB2;MAPK3;SMAD2;MAPK1;TGFB2;RAD51;JAK1;AKT1;RELA;PIK3CB;RPS6KB1;AKT3;PIK3R2;MAP2K1
gsea,Hepatitis B,-0.2146733155860036,-0.9466809202131188,0.5505836575875487,0.6165023341471999,1.0,36/109,29.88%,YWHAB;JUN;BAX;CYCS;YWHAZ;YWHAQ;KRAS;VDAC3;PCNA;BAD;HRAS;PIK3R1;DDB2;ATF2;MAPK3;SMAD2;EGR3;IRAK4;CREB3L2;CREB1;MAPK1;NFKBIA;TBK1;IRF3;NRAS;TGFB2;JAK1;MAVS;AKT1;RELA;PIK3CB;CREB3;AKT3;PIK3R2;MAP2K1;ATP6AP1
gsea,Th1 and Th2 cell differentiation,0.24073437295308794,0.9455370486878666,0.5673289183222958,0.6895597179285123,1.0,12/50,13.88%,MAML2;CHUK;MAPK10;MAPK14;NOTCH2;LCK;JAK2;IKBKB;MAPK12;PLCG1;MAML3;DLL3
gsea,beta-Alanine metabolism,-0.2947365083058908,-0.9411578471004315,0.5124282982791587,0.6248578476279545,1.0,9/23,39.85%,SRM;ALDH6A1;SMS;ALDH2;SMOX;EHHADH;ALDH9A1;ALDH1B1;ALDH3B1
gsea,Basal cell carcinoma,-0.2627635885151267,-0.9325248819223461,0.5539305301645339,0.6396439694051761,1.0,8/40,14.32%,BAX;FZD3;FZD2;HHIP;FZD4;GSK3B;DDB2;WNT16
gsea,Amoebiasis,-0.24449150086686822,-0.9125209929630543,0.5957854406130269,0.6791063290808665,1.0,18/47,26.16%,GNAS;COL4A5;PIK3R1;GNA11;VCL;ARG2;PRKACB;COL1A2;IL1R2;RAB5A;RAB7;PLCB1;RAB5B;RAB5C;PRKACA;TGFB2;RELA;PIK3CB
gsea,Cushing syndrome,-0.20478749402502103,-0.9113775599513947,0.6482504604051565,0.6777554441321683,1.0,27/112,21.20%,GNAS;NCEH1;KCNK2;FZD3;FZD2;CDK4;KCNA4;GNAI1;FZD4;GSK3B;GNAI2;AIP;LDLR;RAP1A;ATF2;GNA11;MAPK3;WNT16;CDKN1B;PRKACB;CAMK2B;CREB3L2;CREB1;MAPK1;PBX1;PLCB1;ARMC5
gsea,FoxO signaling pathway,-0.2014003712797493,-0.8963953505179968,0.6871508379888268,0.7061837443227617,1.0,33/103,29.48%,GABARAPL1;GABARAPL2;PLK2;CSNK1E;GABARAP;KRAS;IRS2;ATG12;HRAS;G6PC3;S1PR1;FBXO32;FOXO4;PIK3R1;MAPK3;CDKN1B;SMAD2;GRM1;MAPK1;NRAS;FBXO25;TGFB2;CCNG2;AKT1;FOXO3;PIK3CB;PRMT1;PTEN;AKT3;PIK3R2;CDKN2D;STK11;MAP2K1
gsea,Signaling pathways regulating pluripotency of stem cells,-0.20928685706917188,-0.8922982127857058,0.6378676470588235,0.7109916284253588,1.0,33/95,30.02%,FGFR2;SKIL;KRAS;FZD3;FZD2;FGFR1;HRAS;INHBA;FZD4;GSK3B;PIK3R1;MAPK3;ID4;WNT16;ID2;SMAD2;KAT6A;BMPR2;ID3;BMPR1B;MAPK1;SMAD9;NRAS;JAK1;DVL1;AKT1;SMAD5;PIK3CB;BMPR1A;AKT3;PIK3R2;MAP2K1;FZD6
gsea,Glycosaminoglycan biosynthesis,0.23161052470106644,0.8919008761902519,0.6579476861167002,0.8065565640033725,1.0,16/45,25.06%,CHST11;EXT2;ST3GAL3;XYLT1;HS6ST3;HS3ST2;EXTL3;EXT1;XYLT2;UST;ST3GAL2;HS2ST1;GLCE;HS6ST2;B3GNT2;CHPF
gsea,Other glycan degradation,0.2990783990242068,0.890954730796162,0.6351931330472103,0.7942580469176215,1.0,4/16,10.84%,HEXA;HEXB;MANBA;HEXDC
gsea,Fanconi anemia pathway,0.2272966769159962,0.8791904649473361,0.7155963302752294,0.8064911323589935,1.0,22/46,29.26%,FANCM;POLK;ERCC4;CENPS;PMS2;FANCD2;RMI1;FANCA;FANCI;POLN;FANCL;FAN1;FAAP100;UBE2T;EME2;RAD51C;FANCB;BLM;POLH;SLX4;REV1;SLX1B
gsea,Toxoplasmosis,-0.21317581712253028,-0.8751885569647243,0.6979742173112339,0.7422366339000992,1.0,23/68,28.53%,HSPA8;HSPA2;CYCS;IFNGR2;BAD;NFKBIB;GNAI1;GNAI2;LDLR;MAPK3;IRAK4;MAPK1;NFKBIA;IL10RA;IL10RB;TGFB2;JAK1;AKT1;RELA;H2-DMA;ITGA6;AKT3;CCR5
gsea,African trypanosomiasis,-0.30559077385566674,-0.8643945590141816,0.6349514563106796,0.7607549407688752,1.0,10/15,42.96%,IL18;PLCB1;HBA-A1;THOP1;HBB-BS;PRKCB;MYD88;LAMA4;PLCB4;HBA-A2
gsea,Adipocytokine signaling pathway,-0.2177492630477677,-0.8542158537977462,0.7339805825242719,0.7766266634038047,1.0,19/51,30.52%,ACSL3;AGRP;IRS2;NFKBIB;G6PC3;ACSBG1;ADIPOR2;NFKBIA;NPY;TRAF2;PTPN11;AKT1;RELA;CPT1C;AKT3;SLC2A1;RXRB;STK11;CAMKK2
gsea,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.2589210122615534,-0.8525589978813968,0.6731517509727627,0.7757826619346525,1.0,4/25,12.11%,PIGK;PIGYL;PIGF;DPM2
gsea,Cortisol synthesis and secretion,-0.22032377975636414,-0.8421545062988335,0.7377690802348337,0.7916388388151738,1.0,13/46,22.35%,GNAS;NCEH1;KCNK2;KCNA4;LDLR;ATF2;GNA11;PRKACB;CREB3L2;CREB1;PBX1;PLCB1;PRKACA
gsea,Gastric cancer,-0.19555060439543365,-0.8420861376886334,0.7495183044315993,0.7873826972996439,1.0,33/100,30.02%,FGFR2;CTNNA3;BAX;KRAS;FZD3;FZD2;HRAS;FZD4;CTNNA1;GSK3B;PIK3R1;DDB2;MAPK3;WNT16;CDKN1B;SMAD2;MAPK1;CSNK1A1;NRAS;TGFB2;DVL1;AKT1;PIK3CB;TCF7L1;RPS6KB1;GAB1;AKT3;RXRB;MLH1;PIK3R2;MAP2K1;FGF5;FZD6
gsea,Circadian rhythm,0.24551527451898403,0.8352007291694346,0.7207920792079208,0.8888575352258404,1.0,5/27,12.68%,PRKAG2;RORA;ARNTL;PER3;BTRC
gsea,Basal transcription factors,-0.22189091030126873,-0.8286538212482252,0.7766990291262136,0.8084565926109708,1.0,18/40,37.07%,TAF10;TAF11;TBPL1;GTF2H5;GTF2B;TAF5;TAF7;ERCC3;TAF7L;GTF2H4;TAF12;TAF6L;GTF2H3;GTF2E1;TAF8;CCNH;GTF2F2;TAF13
gsea,Amino sugar and nucleotide sugar metabolism,-0.21927857650437768,-0.8174443790498631,0.7906976744186046,0.8244478797623656,1.0,15/41,33.58%,PMM1;CMAS;CYB5R3;GMPPB;NANP;GNE;HK1;GNPNAT1;GNPDA1;AMDHD2;UAP1;HK2;PGM3;GFPT2;GALT
gsea,JAK-STAT signaling pathway,0.18887370891212016,0.8108955097896762,0.8340336134453782,0.922494382645843,1.0,16/80,14.42%,RAF1;PIAS2;SOS1;CCND2;JAK2;PIK3R3;AKT2;SOCS2;PTPN2;PIK3CD;SOCS7;MTOR;STAT2;PIAS1;IL6RA;CSF2RA
gsea,Breast cancer,-0.18675154863560828,-0.8061899340719074,0.822550831792976,0.8391937782106317,1.0,16/103,14.47%,JUN;BAX;NFKB2;KRAS;FZD3;FZD2;FGFR1;CDK4;HRAS;FZD4;GSK3B;PIK3R1;DDB2;MAPK3;WNT16;JAG1
gsea,Notch signaling pathway,0.21122400606058364,0.8014050951283253,0.8111587982832618,0.9245953809783597,1.0,20/44,29.41%,MAML2;NOTCH2;HDAC1;DTX1;MAML3;DLL3;APH1C;ADAM17;RBPJ;DVL3;PSEN1;PSEN2;EP300;NOTCH1;NCSTN;DVL2;NUMBL;DLL4;DTX4;CREBBP
gsea,Tryptophan metabolism,-0.23867340714852048,-0.7974384065314923,0.8060836501901141,0.8495708214494231,1.0,11/25,40.20%,MAOB;KMO;ALDH2;EHHADH;GCDH;ALDH9A1;HADH;IL4I1;ALDH1B1;ACAT2;DDC
gsea,Hematopoietic cell lineage,0.22090997981072957,0.793868405487627,0.7885985748218527,0.9225939738670816,1.0,11/36,20.24%,GYPA;FLT3;ITGA3;IL1R1;IL6RA;CSF2RA;KITL;ITGA4;ITGA1;CD44;THPO
gsea,Nicotinate and nicotinamide metabolism,0.24339314243619675,0.7764070171210177,0.7915742793791575,0.936152614258311,1.0,3/21,8.96%,NUDT12;NNT;NMNAT2
gsea,TNF signaling pathway,-0.18885192065355466,-0.7760430600037341,0.8625235404896422,0.8779409900201046,1.0,23/68,29.48%,JUN;JUNB;BAG4;CX3CL1;CEBPB;PIK3R1;ATF2;MAPK3;JAG1;MAP3K8;CREB3L2;CREB1;MAPK1;NFKBIA;CFLAR;TRAF2;AKT1;RELA;PIK3CB;CREB3;AKT3;PIK3R2;MAP2K1
gsea,Bladder cancer,-0.22866310253454278,-0.7726756658818111,0.7953216374269005,0.8786621391986242,1.0,6/27,21.64%,KRAS;CDK4;HRAS;MAPK3;MAPK1;NRAS
gsea,Butanoate metabolism,-0.2470814306460989,-0.7630484124180298,0.7777777777777778,0.8875017055103862,1.0,10/17,45.72%,HMGCS1;OXCT1;ALDH5A1;EHHADH;BDH1;HADH;ACAT2;HMGCLL1;ECHS1;GAD1
gsea,Malaria,-0.25816886789344395,-0.7587949901771159,0.7951582867783985,0.88829222597951,1.0,2/17,5.35%,CD81;IL18
gsea,Arachidonic acid metabolism,0.22320405119614087,0.7518329063135291,0.8299776286353467,0.9561911689571263,1.0,11/27,26.51%,PLA2G4E;LTA4H;CYP2J6;CYP4F13;CYP2U1;PLA2G3;PLA2G4A;PTGS2;PLA2G12A;PTGES2;PLA2G2F
gsea,Sphingolipid metabolism,0.19175304116082864,0.7222707003893554,0.8979166666666667,0.9758507228587016,1.0,14/38,28.58%,CERS4;SGMS1;CERS6;CERS5;SGPL1;GAL3ST1;SPTLC1;CERK;ASAH2;NEU4;SMPD3;ACER3;CERS1;NEU1
gsea,"Valine, leucine and isoleucine degradation",-0.18788918887653205,-0.7213522458336035,0.9033457249070632,0.9259922761186485,1.0,9/42,23.99%,MCEE;HMGCS1;ACAD8;ALDH6A1;DBT;OXCT1;IVD;HSD17B10;ALDH2
gsea,Other types of O-glycan biosynthesis,0.21030856316476662,0.6757430171513419,0.9198473282442748,0.9991774728272274,1.0,2/21,6.89%,ST3GAL3;COLGALT2
gsea,Galactose metabolism,-0.21150552245649856,-0.665139084031745,0.9182879377431906,0.9644858182007223,1.0,3/21,11.29%,LCT;G6PC3;PFKL
gsea,N-Glycan biosynthesis,-0.17307318831575583,-0.6633178885935327,0.9631067961165048,0.9604598244628978,1.0,25/48,40.79%,DPM3;DAD1;DDOST;ALG14;DPM2;ST6GAL1;DPM1;STT3A;ALG13;ALG5;TUSC3;ALG11;MAN1A;MOGS;ALG3;STT3B;ALG6;SRD5A3;ALG1;B4GALT2;RPN1;MGAT4B;MGAT2;ST6GAL2;B4GALT3
gsea,Ether lipid metabolism,0.19101161766137575,0.6549422384920008,0.9311064718162839,0.9960240704921556,1.0,18/32,34.35%,PLA2G4E;AGPS;GDPD1;GAL3ST1;PAFAH2;PLA2G3;PLA2G4A;ENPP2;ENPP6;PLA2G12A;PLA2G2F;SELENOI;PLD2;PLB1;LPCAT2;PLA2G4B;GDPD3;CEPT1
gsea,Herpes simplex virus 1 infection,0.12394135117399606,0.6441027745797996,1.0,0.9864751528771852,1.0,64/295,21.95%,POU2F2;CHUK;ZFP950;NECTIN1;TRAF3;ZFP189;MAP3K7;ZFP951;ZFP607A;ZFP157;JAK2;PIK3R3;ZFP382;ZFP944;IKBKB;AKT2;ZFP52;ZFP398;HCFC2;ZFP286;ZFP128;CFP;GM14391;PIK3CD;ZFP9;ZFP948;MTOR;STAT2;ZFP61;ZFP40;ZFP810;SRSF1;ZFP568;ZFP53;SRSF5;SRSF6;ZFP60;ZFP472;ZFP354A;ZFP949;RBAK;GM12258;EIF2S1;ZFP667;IRF9;ZFP78;ZFP108;ZFP994;NFKB1;RSL1;ZFP160;GM14393;ZFP879;NXF1;PIK3CA;APAF1;ZFP788;ZFP715;SRSF4;ZFP811;ZFP626;ZFP960;ZFP418;ZFP958
gsea,Aminoacyl-tRNA biosynthesis,0.12008416506714757,0.44675962546094367,0.9956140350877193,0.9995747889990694,1.0,11/42,23.59%,LARS2;FARSA;MTFMT;RARS;SARS;NARS2;IARS;VARS2;SARS2;YARS;DARS2
